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aureus catabolized glucose by both the Embden-Meyerhof (EM} and the
hexosemonophosphate (HMP) pathways, as determined with 14c~labeled glucose.
The relative activities of these pathways, and of the TCA cycle, were influenced by the inclusion of niacin and/or thiamine in the growth medium.
When > 0.25 µg/ml of niacin was added to 2% Vitamin-free Casitone, the pro~
portion of glucose metabolized via the HMP pathway by 2_. aureus was stimulated 3-fold. When O.l µg/ml of niacin was added, the growth was maximally
stimulated but increased NAD(P) synthesis or HMP pathway activity was not
observed. Under growing conditions, increased glucose oxidation via the HMP
pathway and TCA cycle activity were correlated with the increased synthesis
of NADP-specific glucose-6-P dehydrogenase and isocitrate dehydrogenase,
deficient cells, metabolic changes similar to those in growing cells occurred,
even in the presence of protein inhibitors such as chloramphenicol, puromycin
or actinomycin D. Since the specific activities of the enzymes tested remained
unchanged under conditions that precluded new enzyme synthesis, the enzyme
levels were not the limiting factors for glucose oxidation via the HMP pathway,
In order to determine if either NAO and/or NADP were regulating the HMP
pathway activity, the staphylococcal suspensions were starved for 6 hr in
buffered-glucose (pH 7.0), under conditions that allowed the NAO to decrease
and NADP to remain constant, During the period of starvation the initial NAO
level decreased to l µmole/g and the percent of ~lucose oxidized via ·the HMP
pathway decreased to 9%, reaching a value of 6% after 6 hr at which time the
NAO content was further ~educed. to 0.5 µmole/g. When niacin was added, the
NAO levels and the HMP activity in these cells were increased to ·1,2 µmoles and
16%, respectively, after 2 hr of additional incubation. These results indicate
that NAO is regulating the activity of this expandable (6 to 22%) HMP pathway,
by increasing NADP turnover via the transhydrogenase system.
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Any of several 1-,2-,3- and 4-substituted niacin analogs completely
replaced the niacin requirement for both growth and the HMP pathway utilization when added at high concentration (ca. 1000 µg/ml} to either a
synthetic medium or Vitamin-free Casitone supplemented wtth thiamine. On
the basis of their effects on growth and on the HMP pathway the analogs
we;·e classified into 4 groups. The 22 goup I analogs, including pyridine-Noxide, pyridine-3-sulfonic acid and 3-acetylpyridine, stimulated both growth
and the HMP pathway maximally while the 9 group II analogs, such as picolinic acid,
stimulated growth and the HMP pathway to a lesser extent, There were 13 analogs
from group III, including 6-hydroxynicotinic acid, that were without effect
while 4 analogs from group IV, including 6-aminonicotinamide, were inhibitory.
Parallel experiments in this laboratory using labeled quinolinic acid, isoniazid
and pyridine-N-oxide indicated that the.analogs were converted to NAD(P) and
llUI.
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labeled compounds and 14c-niactn, it was suggested that the need for high
concentrations of analogs for growth was due to the absence of active transport
for these compounds and the analogs entered the cells by simple passive diffusion
to cause biochemical changes .similar to those caused by niacin,
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INTRODUCTION
Glucose is the main metabolic fuel for living cells, providing both energy and intermediates for various biosynthetic
reactions.

Al though important. insights have already been

obtained during the past decade into the regulatory mechanisms
which influence microbial activities such as amino acid biosynthesis, the same degree of knowledge is not available for
the regulation of carbohydrate metabolism.

In bacteria the

control mechanisms for individual glycolytic pathways, particularly the Embden-Meyerhof (EM} pathway, are known to a moderate
degree.

For example, when cells catabolize glucose via the EM

pathway, phosphofructokinase plays an important regulatory role

glucose from smaller molecules through a reversal of the EM
pathway, then the enzyme fructose-1,6-diphosphatase plays the
important role of controlling the activity of this pathway.
The situation is more complex when we wish to learn about the
factors that control the amount of glucose being utilized by
the two pathways that can both utilize glucose within the
cells, the EM and the hexosemonophosphate {HMP) pathways.

By

comparison, very little is known about such regulatory factors.
Although the importance of the vitamins niacin and thiamine
in microbial glycolysis is known, their effects on the individual- glycolytic pathways are relatively unexplored.

Regulation

of the HMP pathway by the availability of NADP and by the levels
1

p
2

of some glycolytic enzymes has been demonstrated in various
bacteria.

However, NAD has not been shown to be involved in

the control reactions of the pentose phosphate pathway.

The

lack of information on the role of NAD from a regulatory point
of view mainly stems from the fact that NAD does not generally
serve as a coenzyme in the HMP pathway.
The present study is an extension of an earlier study
which had shown that the addition of niacin resulted in a 3to 4-fold stimulation in utilization of the HMP pathway of

s.

aureus and a concomitant decrease in the percentage of

glucose metabolized via the,.E;M pathway.

In order to investi-

g ..... L ..:

.Lt::i::f u:i..cu• .i.vu 0;:

;:;-.;ln<:. 0£

th..:.: factors involved in t.be

':I :i..u. .... vSb

oxidation via the HMP pathway, the levels of glycolytic enzymes
and

of nicotinamide coenzymes were studied in cells under

conditions in which the HMP' pathway was increased or decreased.
Also, niacin analogs were employed in these studies in an
attempt to obtain more information about the regulatory role of
NAD(P).

Since niacin analogs were found to completely replace

niacin, some studies on the mechanism of niacin replacement by
the analogs were also initiated.

~··

I.

REVIEW OF LITERATURE

.Glycolysis usually serves to satisfy various cellular
requirements such as energy and precursors for biosynthesis.
In addition glycolysis serves to convert these precursors
into useful intermediates for the appropriate cellular reactions.

Stapnylococcus aureus metabolizes glucose aerobically

or anaerobically by both the Embden-Meyerhof (EM) and the
hexosemonophosphate (HMP) pathways (88, 113), with the EM being
the major pathway.

Under aerobic conditions the pyruvate is

co 2

further oxidized to water and
(TCA) cycle (94,111).

via the tricarboxylic acid

So far there is only negative evidence

in the literature for the occurence of the
c,t<:i>J

in staphylococci

n;:it:hwr:iv

~ntner-Doudoroff

(113).

The HMP pathway (also known as the pentose phosphate
pathway or the pentose cycle) for glucose catabolism is widely
distributed in microorganisms.

The pathway provides a route

of glucose oxidation that is independent of the TCA cycle and
of glycolysis by the EM pathway.

It is a generator of NADPH

and of 4 and 7 carbon sugars necessary for various biosynthetic
processes.

It is also a source of ribose, an intermediate

•

product of this pathway that can be used for synthesis of
nucleic acid.
Operation of the HMP pathway along with the EM pathway
during glycolysis became apparent in a wide variety of living

3

4
cells.

s.

During the investigation of biochemical changes in

aureus, some evidence indicating the operation of the HMP

pathway was obtained, by measuring the rate of formation of
14co 2 from glucose-1-14c and glucose-6-14c (19, 38).
Oxidation of glucose has been st.udied in

s.

aureus in

the presence or absence of arsenite, an inhibitor which
causes the accumulation of pyruvate and thus blocks the
further oxidation of pyruvate via the TCA cycle (113). In
the presence of this metabolic inhibitor, considerable amounts
of 1 4 co2 were recovered during the oxidation of glucose-1-14c
and glucose-u- 14 c.
~l..l.c:l1..t:u

Thus the results of these studies demon-

1..ut: ::.irnultant:ou::. Uf:Jt:rai.ion o.i:

the hlvlP pathway

alum~

with the EM pathway and established the importance of the
HMP pathway in staphylococcal carbohydrate metabolism.
Estimation of the glucose catabolic pathways also
indicated that about 64% of the glucose was oxidized via the
HMP pathway by resting cell suspension previously grown in a
broth lacking glucose .

When glucose was added to the

nutrient broth, glucose oxidation through the HMP pathway
decreased from 64% to 34%.
tion of the TCA cycle.

In addition there was an inhibi-

Studies on various individual glyco-

lytic enzymes were also made and evidence for re9ression
(i."e., inhibition or suppression of the synthesis of enzymes)
was obtained when glucose was present in the medium (16,49,

5

113).

This effect of glucose has also been reported .for

other microorganisms, such as Bacillus subtilis, Escherichia

-

coli and Thiobacillus intermedius

(36,39).

Glucose repression of cellular activities is not limited

to microbes.

For instance, glucose inhibited the glucose

oxidation via the TCA cycle in ascites tumor cells: however,
it increased the oxidation of carbon-1 of glucose, presumably
by the HMP pathway (95).
demonstrated in

s.

At the same time it was also

aureus that addition of glucose to the

growth medium reduced both the oxidation of glucose by the
HMP pathway and the subsequent oxidation of pyruvate via the

The iron content of the medium also has a significant
effect on the glycolytic pathways in staphylococci (116).
The metabolic activites of

s.

aureus grown in an iron-poor

and in an iron-rich Trypticase medium, with and without
addition of glucose,were compared.

It was found that

i~

the

absence of glucose, iron-rich cells oxidized glucose and
other substrates more efficiently than did the cells grown
in the iron restricted medium.

The addition of glucose

under the same conditions resulted in severe reduction of
the oxidative capacity of the iron-restricted cells, compared
to ·that of iron-rich cells.

From these results it was conclu-

ded that the metabolic activity of S. aureus was affected by

6

both the amount of iron in the medium and by the presence or
absence of glucose.
The effects of a number of different physical and physiological conditions that might alter the glycolytic pathways
in

s.

aureus have been studied by various workers and reviewed

by Blumenthal (5).

The effect of vitamins on the glycolytic

pathways have not been extensively investigated in microorganisms.

A thiamine deficiency in red blood cells is

known to diminish the activity of the HMP pathway since DPT,
the coenzyrne form of thiamine, is a coenzyme for the HMP
pathway enzyme transketolase.

It has been shown that. the

""'C<l.i.:::.lon of thiamine Lo thiamine deficient. ..::c.;.d Llv...Jd <.;ell;:,;

stimulated the activity of transketolase which iri turn
stimulated the HMP pathway (102).
Earlier studies with staphylococci yielded information
of a general nature.

A certain relationship between niacin

and thiamine and the utilization of glucose by staphyl?cocci
was observed (61).

In order to elucidate the specific roles

of these two vitamins in glucose metabolism by this organism,
staphylococci were grown in 10% Vitamin-free casein hydrolysate containing constant amounts of niacin and thiamine
(1.0 µg/ml).

It was demonstrated that there was an active

aerobic growth of staphylococci in the presence of niacin
alone, with only partial utilization of glucose.

The amount

7

of glucose metabolized was only about 40% of the amount used in
the presence of niacin and thiamine.

Analysis of the end

products of glucose catabolism also indicated that thiamine
catalyzed the oxidation of pyruvate only in the presence of
niacin; however, specific effects of these two vitamins on the
glucose catabolic pathways were not investigated.
The formation of niacin coenzymes, NAO and NADP,from niacin
with the subsequent stimulation of glycolysis in S. aureus has
been noted (47).

During the investigation on the effects of

some niacin analogs on glycolysis, marked glycolytic inhibition
as a result of the addition of niacin analogs was noted.
ui1

1...i:it:!::>t~

Based

resuJ..ts it was suggested that the ana.Logs probab.Ly

acted by interferring with the staphylococcal synthesis of
nicotinamide coenzymes.
labell~d

Montiel and Blumenthal (81), using

glucose to estimate the pathways in living cells,

showed that the addition of niacin and thiamine to the growth
medium had significant effects on the degree of operation of
the EM and the HMP pathways.

They reported that the addition

of ni.acin to the growth medium increased the operation of the
HMP pathway, while both niacin and thiamine were necessary for
maximal stimulation of the TCA cycle activity.

The effect of

niacin and thiamine on the coenzyme levels was investigated
(44)".

It was shown that when niacin was added to the medium,

there was a 15- to 30-fold increase in NAD level and only a

8

2-fold increase in NADP, NADH and NADPH levels in staphylococci.
This increase in the coenzyme contents due to the vitamins was
also followed by stimulation of glycolysis ins. aureus (45).
Participation of glucose catabolic pathways in microorganisms.

Wang et al.

(119) introduced the radiorespiro-

metric method for the estimation of the glucose catabolic
pathways.

This method has been widely and successfully used

to evaluate the glycolytic pathways in many different bacteria.
Based on this technique it was reported that in Pseudomonas
natrigens 92% of the glucose was catabolized via the EM
pathway, whereas 8% was oxidized via the HMP pathway.

Escherichia coli was 72% and 28%, respectively (23).

The

On the

other hand, complete absence of the EM and the ED pathways
was noted in Acetobacter suboxydans, with all of the glucose
catabolized via the HMP pathway (60).

Similarly, the EM and

the HMP pathways were shown not to be operative in Pseudomonas
saccharoohila (12).

When S. aureus was grown in Trypticase

soy broth (which contains glucose), the simultaneous participation of the EM and the HMP pathways was 88.7% and 11.3%,
respectively (4).

Montiel and Blumenthal (81) studied the

effects of vitamins on glucose catabolic pathways in various
strains of S. aureus and

~-

epidermidis.

Their findings

demonstrated that in the presence of niacin and thiamine
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roughly 14-40% of the glucose was oxidized via the HMP pathway
by staphylococci.
Generally, in purely biosynthetic pathways the major
control exerted is the negative feedback control.

In this

type of control process, the end product or the metabolite
represses the synthesis and/or inhibits the activity of the
first enzyme of that pathway.

In catabolic pathways, however,

the activity of initiating enzyme is generally controlled by
compounds which serve as indicators of the energy state of a
cell such as inorganic phosphate, pyrophosphate, purine or
pyrimidine nucleotides.

Occurance of cooperative feedback,

-..J•·--- ._._""""'
., ..• ~ :

=·· ': ,~
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tion have been studied in detail (84, 90, 127).
The various control mechanisms involved in amphibolic
pathways (i,e., metabolic pathway pro_viding both anabolic and
catabolic functions) have been recently reviewed by Sanwal
(101).

There are various diverse control mechanisms present

which differ in details from microbe to microbe, although the
main types of control mechanisms are the same.

•

This is in agree-

rnent with the concept of "unity of biochemistry".
citrate synthase in

For example,

_animal (SO), in Yeast(89) or in B. subtilis

(28) is inhibited by ATP, while in E. coli it is inhibited by
NADH and a-ketoglutarate.

In the case of aerobic Gram-positive

bacteria such as staphylococci, the enzyme is not regulated by

L

r

.

.
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either ATP or NADH, and probably some other different control
mechanism may be present in these organisms.

Moreover, many of

the control mechanisms have been studied extensively only in
E. coli and in few other Gram-negative bacilli.

-

-

More detailed

studies are needed in other groups of bacteria before a
generalization can be made about the regulatory process.
Recently it was reported that fructose-6-phosphate, glucose-6phosphate and AMP inhibited the activity of two enzymes in the
aspartic acid family of E. coli

(2).

This example of the

control of amino acid biosynthesis by glycolytic intermediates
of the EM and the HMP pathways again indicates the extent and
importance of this type of control

mechanis~_
~

..,

.

;

There is considerable evidence indicating that the activity
of the hexosemonophosphate pathway may be partly controlled by
the supply of NADP.
acceptors

The presence of artificial electron

(9) or the supply of substrates which require NADPH

for their metabolism (42, 57) can increase the rate of formation
of 14 co 2 from glucose-1- 1 4c, suggesting active operation of the
HMP pathway.

Similar effects have been observed in other

animal tissues such as erythrocytes (8), corneal epithelium (59)
and ascites tumor cells

(121).

The HMP pathway in erythrocytes

was shown to be dependent on the availability of NADP
Later Smith and Stourman,

(18).

(110) using a hemolysate preparation

of red blood cells, confirmed the enhancement of the HMP pathway
activity following the addition of NADP to the extract.

High

11

activities of glucose-6-phosphate and 6-phosphogluconate
dehydrogenases together with the marked increase which occurred
in the oxidation of carbon-1 of glucose when artificial electron
acceptors were added to the medium indicated that the activity
of the HMP pathway was limited by the supply of NADP (79}.
The operation of the HMP pathway in P. natrigens was rate
limited by the supply of NADP (24}.

This was based on further

studies on the rate of oxidation of NADH and NADPH and the
activity of transhydrogenase in crude extracts from a number of
organisms in which estimates of the relative degree of operation
of the EM and the HMP pathways had already been made.

A strong

cor:r·:::ls..Lion t:Jas found between Lti.ose :micrubes whose extracts
possessed an active NADPH oxidase and transhydrogenase and
those organisms which predominantly oxidized glucose through
the HMP and/or ED pathways.

The activities of

~hese

.enzymes

were absent in the organisms mainly utilizing glucose by the
EM pathway.

Rate limiting effects of NADP might also be over-

come by the presence of two initial enzymes of HMP pathway
that could utilize either NAD or NADP as cofactors (13}.

Such

enzymes are extremely rare.
Thus the activities of the glycolytic pathways can be
controlled by the availability of cofactors as well as by the
levels of adenine nucleotides.

In addition to this control by

the nucleotides, the regulation of these pathways can be

l
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influenced by the variation in the amounts of certain key ·enzymes
of the pathway.

Osmond and ApRees (87) suggested that in yeast,

control of the HMP pathway occurred by variation in the amount
of some enzymes.

They tested the activities of certain enzymes

of both EM and the HMP pathways in extracts of yeast grown either
in simple medium containing nitrate as the sole nitrogen source,
or in a complex medium containing all of the amino acids.
Measurement of the enzyme activities was also correlated with the
estimation of 14co 2 production from -1-14c and -6-14c-glucose.
Their findings demonstrated that the activities of G6PD and
transketolase were significantly higher in extracts of yeast

on the complex amino acid medium.

Increased enzyme activities

paralleled increased 14 co 2 liberation from glucose-1- 14 c,
providing a rough measurement of the HMP pathway activity.
Similarly, yeast cells were first grown in the complex medium
and then transferred to the simple med·ium; this also resulted
in the increased synthesis of the same enzymes of the HMP
pathway.

On the basis of these results they suggested that the

increased amount of G6PD and transketolase- indicated that
adaptation to carbohydrate oxidation via the HMP pathway involved synthesis of more enzymes.
Regulation of the glycolytic pathways also depends on the
induction, activation or inhibition of the glycolytic enzymes
by vitamins, metabolites or coenzymes.

For instance, induction

r

'
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of G6PD synthesis by NADP, NADPH and by other compounds, such
as nitrobenzimidazole, has been observed in animal and microbial
cells (3, 105), indicating their role in the glycolytic control
mechanisms.

Thiamine, in the form of diphosphothiamine {DPT),

has been shown to induce the synthesis of pyruvate decarboxylase
in yeast, with a resultant increase in the rate of glycolysis
(123).

DPT is actually the coenzyme for pyruvate decarboxylase

apoenzyme.

This finding was based on the observation that

pyruvate decarboxylase activity increased by 50% during the
incubation of yeast cells with glucose and thiamine and by 300%
when the cells were incubated with glucose, thiamine and nitrogen

induced by thiamine, was prevented by the inclusion of proflavin,
p-fluorophenylalanine or 5-fluorouracil in the incubation medium.
These results indicated that the reason for the higher activity
of pyruvate decarboxylase, after incubation with thiamine, was
a result of the stimulation of the de novo synthesis of the
enzyme and not of an activation of preexisting enzyme molecules.
There are also other examples of this type in animal tissues
(37) •

Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the
oxidation of glucose-6-phosphate and thus introduces hexose into
the pentose cycle.

Since this is an important branching step in

hexose metabolism, it is likely that this enzyme would be sub-

~ jected

to regulatory control.

The G6PD from Pseudomonas

r
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aeruginosa was strongly inhibited by ATP, GTP and

dGTP by

decreasing the binding of the substrate to the enzyme and it
was suggested that adenine nucleotide control of the activity
of G6PD might regulate the overall degradation of glucose
under conditions requiring gluconeogenesis (70).

A similar

inhibition of G6PD of E. coli by ATP was noted, indicating
that adenine nucleotide control of activity of allosteric
enzymes may be of general importance (1).

Recently it was

reported that the activity of the G6PD of E. coli was inhibited
in an allosteric manner by NADH.

Although this inhibition of

G6PD by.· NA.DH has not been opi;;er.ye9 i.n ot,he.r, ,bact,e,r~}lJ .species
tPst~dr

it does appear to play a signific::mt "l"'nlf> i.n C"O:nt:rnJling

the enzyme activity in E. coli (100).
If a cell has excess of ATP, it would appear logical to
assume that it would have a feedback mechanism to slow down the
glucose catabolism that is leading to the generation of more ATP.
It was demonstrated that ATP and GTP were competitive inhibitors
of G6PD, the important HMP allosteric enzyme in ascites tumor
cells, while only 6PGD was sensitive to GTP

(7).

Schindler and

Schlegel (103) concluded from their studies of G6PD from various
microorganisms that G6PD functioned only in catabolism and that
these enzymes were subjected to adenylate control with ATP as
a negative allosteric effector.

It is generally believed that

phosphofructokinase is an important regulatory enzyme for the

Lactivity of the EM pathway and this it also is inhibited by

15
excess ATP and activated by AMP (117).

If ATP is capable of

inhibiting the key H..l'1P pathway and the key EM pathway enzymes,
high cellular levels of A'I'P should depress the total amount of
glucose catabolism in the cell.

This provides a sensitive and

efficient mechanism for the regulation of the metabolic pathways (72, 93).
There is very little evidence regarding the control of
other enzymes in the HMP pathway.

The activity of transketolase

was found to be limiting the HMP pathway activity in thiaminedeficient red blood cells (102).

In addition, it has been

reported that transketolase was the rate-limiting enzyme in

\ v,

1.-

85).

In yeast, variation iri transketolase activity was observed

to parallel the degree of operation of the HMP pathway (87).
Significance of this increased activity of transketolase may be
that it prevented the accumulation of erythrose-4-phosphate, an
inhibitor of glucose-phosphate isomerase, and allowed increased
activity of the HMP pathway without any inhibition of the overall
glycolytic rate.
The tricarboxylic acid cycle (TCA) functions mainly as an
energy yielding process and also provides many precursors for
cell biosynthesis and growth.

The intermediates and biochemical

reactions of this cycle have been extensively studied in numerous
biological systems {67).

L

Since many biosynthetic pathways

•
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originate from the TCA cycle and many reactions of the cycle are
important for the production of energy, it is likely that many
of the enzymatic steps of this pathway are subjected to regulation by various effectors.

One of the allosteric enzymes of

this pathway has been found to be isoci trate dehydrogenase (ICD.>.
This allosteric enzyme can thus increase or decrease the activity
of the TCA cycle (75, 98, 99).
The control mechanisms for the activation of ICD are not
fully understood.

It has been demonstrated in Neurospora, and

also in yeast (98) that the affinity of

th~

substrate for the

enzyme increases dramatically in the presence of AMP.

This

regulation of the TCA cycle.
It has been suggested that the tricarboxylic acid cycle may
be rate limited by the supply of NADP, since isocitrate
dehydrogenase was shown to require NADP as a cofactor (14).
In microorganisms two types of isocitrate dehydrogenases have
been reported (101).

NAO-specific isocitrate dehydrogenases

are part of the normal function of the TCA cycle in the oxidation
of substrate for the generation of

energy~

whereas NADP-specific

isocitrate dehydrogenases are coupled to biosynthetic pathways
originating from TCA cycle (34, 99).
Both niacin and thiamine have been considered to be
essential vitamins for the growth of S. aureus for over 20 years.
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In fact, it was with S. aureus that niacin was first proven to
be a vitamin requirement for living cells (63).

Although niacin

remains as an absolute vitamin requirement for the growth of
5. aureus, thiamine is no longer considered as an essential
vitamin.

Idriss and Blumenthal (48)

d~veloped

a new thiamine-

free synthetic medium for S. aureus which supported a moderate
growth of staphylococci (OD, 0.2 in 10 hr) in the complete
absence of thiamine when pyruvate or glucose was the carbon
source.

However, added thiamine still stimulated growth in an

otherwise complete medium.

Thus the inclusion of thiamine in

the medium tripled the amount of growth •
.i:ulluwiw:.i 1...Ht: iHiL.Lal. ui&l;O\fer.y C:lW:i iUt::!il\.if.L~d.t....LUU u.i.
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vitamins, a survey was made of the ability of several compounds
closely related to niacin and thiamine to replace them as a
growth factor for the growth of various bacteria (62, 63, 68,
69).

The results of the studies showed that only a very limited

departure in structure of the two vitamins could support the
growth of staphylococci.

S. aureus was the original microbe

that was shown to require preformed nicotinic acid for growth.
The utilization of a number of compounds related to nicotinic
acid by various bacteria

(i.e.,~-

aureus, Proteus vulgaris,

Shigella dysenteriae and Lactobacillus plantarum) was studied

by a.number of workers (26, 27, 62, 73, 91); the results of
these investigations have been well summarized by Koser (66).
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The utilization of a number of isomers of nicotinic acid by
5 • aureus was studied, using amino acid-glucose medium (27, 69).

-

The analogs were tested in the presence of thiamine (0.005 µg/ml)
in the medium.

Using concentrations of niacin isomers up to 2.0

µg/ml, it was reported that with the exception of nicotinuric
acid, none of the following compounds could replace niacin in
supporting growth of

s.

aureus:

nicotinyldiethylamide,

quinolinic acid, 2-methylpyridine, or isonicotinic acid.

On the

basis of these results it was concluded that the ability of

s.

aureus to utilize.compounds related to niacin was very limited

(68, 69).
Knight and Mcilwain (63) investigated tne

abi~ity

or a

series of pyridine derivatives to replace niacin, by adding them
to a basal medium which was nutrionally adequate for the growth
of §_. aureus,· except for niacin.

All the analogs were tested

at a concentration of 10-4M in the presence of excess thiamine
(l0- 7M); the growth was measured for a period of 3 days under
aerobic conditions.

They reported that quinolinic acid,

picolinic acid, isonicotinic acid, pyridine-3-sulfonic acid,
•
3-picoline and several other related pyridine derivatives could
not replace niacin in supporting growth of

s.

aureus.

On the

basis of these results they suggested that niacin and thiamine
were highly specific in their growth requirement for

L
.

s.

aureus.
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Pyridine-3-sulfonic acid (PSA), the sulfur analog of
niacin, was ineffective in replacing the niacin requirement
for the growth of Proteus species.
inhibited the growth of
an antimetabolite.

s.

However, it strongly

aureus, presumably by acting as

The effect of various concentrations of

pSA on the growth of

s.

aureus in the synthetic medium

containing niacin and thiamine was studied (78).

It was

found that the addition of PSA (10-2M) to the medium containing nicotinarnide (10-6M) resulted in growth inhibition that
was reversed by th~ ~dditi9h of higher arn9unt~.of niacin.or
,

niacinarnide.

,.,
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On the other hand, it was reported that PSA and

its amide had some growth stimulating action on

~-

vuigaris

-ands. aureus at a relatively high concentration -(97).

Simi-

larly, complete replacement of the niacin requirement of
Shigellae species by PSA -Cl mg/ml) has been observed (92).
The mechanism by which PSA substitutes niacin is not
clear.

It is possible that there is either a conversion of

PSA to niacin or that PSA itself is incorporated to yield a
coenzyme analog which is biologically functional.
Wooley (126) observed that 3-acetylpyridine (3-AP) was a
niacin antagonist in animals.

3-AP differs from niacin by

the replacement of an acetyl group for the carboxyl group.
Although this analog could not support the growth of a
number of microorganisms, it did substitute niacin to some

L
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extent for some niacin-requiring strains of dysentry bacilli
(82).

The toxicity of 3-AP in animals was shown to be due to

the formation of abnormal coenzyme.

For example, the formation

of the 3-AP analog of NAD in the brain and in the spleen of
mice was demonstrated after the administration of 3-AP (53, 54).
In this case, the 3-AP replaced the nicotinamide moiety of NAD.
The 3-AP analog of NAD was the first one that was found to
be active with a number of dehydrogenases.

3-Acetylpyridine-

NAD (APNAD) was shown to serve as a coenzyme with yeast alcohol
dehydrogenase at approximately 10% of the rate at which NAD
served, while pyridine-3-aldehydeNAD (Py-3-NAD) reacted at a
consiaerably s.Lower rate.

With horse alconol. aehydrogenase or
-

with glutamate dehydrogenase, both APNAD and Py-3-NAD reacted
more rapidly than the normal NAD (53, 54).
A large number of compounds related to dipicolinate, an
analog of niacin, were investigated for their ability to replace
dipicolinate in restoring sporulation in a mutant strain of
Bacillus megaterium.

Of the compounds tested, only 4-H-pyran-2,

6-dicarboxylic acid and dipicolinic acid-N-oxide were effective
in restoring sporulation and heat resistance.

However, 4-H-

pyran-2, 6-dicarboxylic acid was found to be more effective than
the natural compound, dipicolinate, in these respects (31, 32).
In animals, 6-aminonicotinamide (6-AN) has been shown to
be a potent analog of niacin.

L

The toxic effects of 6-AN upon
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injection into animals are due to its incorporation into
analogs of NAD and NADP (52).

Formation of 6-AN-NAD has also

been demonstrated in vitro (21, 22) and it is a competitive
inhibitor of several NAD- and NADP-dependent enzymes (17).
Dietrich et al.

(22) studied the effect of 6-AN administra-

tion on the activities of several NAD linked enzyme systems
in animal adenocarcinoma and found that the activity of
lactate dehydrogenase was unaffected by the coenzyme analog,
while 3-phosphoglyceraldehyde dehydrogenase and a-ketoglutarate oxidase activities were markedly inhibited.
Concomitantly, there was a significant

-other organs.

decre~se

in the

Decreased levels of NAD and NADP following

the administration of 6-AN, were also observed in ascites
tumor

cell~

(12).

There was a considerable decrease in the release of 14 co 2
from glucose-1-14c, when 6-AN treated animal tissues were used
for the metabolic studies (40, 41).

This and other data

indicated that there was an inhibition of the two initial
•
NADP-dependent enzymes of the HMP pathway in vivo. The
inhibition was shown to be more significant at the 6PGD level
than at the G6PD level.

This was based on the finding that

larger amounts of 6-phosphogluconate were accumulated in the
brain of 6-AN treated animals compared to glucose-6-phosphate.

L
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various other biochemical reactions outside the HMP pathway,
are also inhibited by 6-AN.

For instance, it has been reported

that there was an inhibition in the incorporation of glucose
intermediates into DNA, P.NA and proteins.

However, these

adverse effects were probably secondary to the inhibition of
the HMP pathway activity (64).
The effects of niacin analogs on the growth of various
niacin-requiring microbes in a synthetic medium containing
minimal amounts of niacin, were investigated (114).

The

results of these studies indicated that the growth of streptococci, E. coli and Lactobacillus plantarum were completely
inru.oit:ecl .Uy

.::>-i.Luu.r.unit:;uL..J..uil..:! ac.J..d

added
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v.i..

0.05 to 1.0 µg/ml, but this concentration failed-to inhibit
the growth of

s.

aureus.

However, 5-fluoronicotinamide in the

same concentration was most inhibitory to the growth of
~·

aureus, E. coli and of streptococci.

The growth of L. pla-

ntarum, S. aureus, P. vulgaris and of E. coli was inhibited
by five halogenated nicotinic acid derivatives in the following
order of decreasing effectiveness:

5-fluoro-, 5-bromo-,

2-fluoro- and 6-fluoronicotinic acid (47).

Such inhibition

of microbial growth was reversed by the addition of niacin,
niacinamide or NAD to the growth medium.

According to

Streightoff (114) replacement of the 5-fluoro group with an
amino, bromo, chloro, dimethylamine, hydroxyl or other

L
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groups resulted in loss of inhibition of growth of streptococci.

Changing the fluoro group from 5th to 6th position

on the pyridine ring also

r~sulted

little inhibitory activity.

in a compound with very

In comparison when amino

group was on the 4th or 6th position the compound exhibited
significant growth inhibitory activity (114).
Since there are contradictory reports in the literature
on the growth effects of these niacin analogs, studies were
undertaken to explore their effects on the growth of

s.

aureus.

Niacin analogs such as 3-acetylpyridine and 6-aminonicotinamide
have been studied extensively in animal system and their toxic
0ttributed to change=
- bolic pathways and in enzyme and coenzymes involved in these
pathways.

Therefore, it was of interest to investigate the

effect of these analogs

on the glucose catabolic pathways

and on the coenzymes in S. aureus.

This

~ould

give us an

excellent oppertunity to study the relation of the glycolytic
enzymes, nicotinamide coenzymes NAD(P) or analogs of these
coenzymes to the glucose catabolic pathways.

L

II.

MATERIALS AND METHODS

Bacterial cultures.

Most of the experimental work was

performed with Staohylococcus aureus, strain Towler, originally
obtained from Dr.

w. c.

Noble, St. Mary's Hospital Medical

school, London, England.

Strain 18Z was received from Dr. F.

Kapral, Ohio State University, Columbus, Ohio, while strain
23 was received from Dr.
Canada.

s.

Cloutier, University of Montreal,

S. aureus serotypes 1 to 4 and S. epidermidis ATCC

w.

115 and 12228 were obtained from Dr. W.
department.
~~-~

~~taine~

Strains
~~om

of~·

the

Yetis of this

flexneri, P. vulgaris and P. morgani

dcpart~ental

cultur:

::l!:~~~:~-

The stock cultures of the organisms were maintained on 4%
Trypticase soy agar {Baltimore Biological Laboratories,
Baltimore,_ Maryland) at 4 C and were transferred to fresh
slants every 2-3 weeks.
Media
a.

Preparation of liquid media.

Vitamin-free

Casi tone {Difeo Laboratories, Detroit, Michigan.) was use_d
extensively throughout the studies.

•

The medium was prepared

in 2% concentration in distilled water and dispensed in 100 ml
aliquots into specially cleaned 250 ml Erlenmeyer flasks.

All-

flasks were cleaned by boiling in distilled water containing
2% (V/V) Fl-70 Biograde detergent(Fisher Scientific, Pittsburg,

L
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pa.) and rinsed several times with distilled water.

This step

was necessary in order to eliminate any traces of vitamins
remaining in the glassware.

The medium was sterilized by

autoclaving at 121 C for 15 min.

Sterile vitamin solutions

were added aseptically to these flasks, whenever needed.

The

preparation and concentration of the vitamins used are
described later.
Preparation of synthetic medium. · The synthetic medium of
Idriss and Blumenthal (48) was prepared and sterilized by
membrane filtration (type HA, 0. 45
Filter Corp., Bedford, Mass.).

- the medium.

µ

pore size, _Millipore

Autoclaving of the medium was

The complete composition of the medium has been

described by Idriss and Blumenthal (48).
Preparation of vitamins and niacin analogs.
thiamine and the niacin analogs were
sterilized by membrane filtration.

separ~tely

Niacin,
prepared and

For the sterilization of

the vitamins or analogs, sterile Millipore 'Swinnex' filters
containing a membrane (0.45

µ

pore size ) were used.

Stock

solutions of the vitamins and niacin analogs were prepared
in deionized distilled water in various concentrations and
were stored at 4

c

for not more than 2 weeks.

The vitamins

or. the analogs were added aseptically to the sterile medium
when it was cool.

L
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Growth conditions.

In all experiments the starter culture

was prepared in the following manner.

A loopful of cells from

the stock culture was plated on a Trypticase soy agar plate
and incubated at 37 C for 18-24 hr.

A loopful of these -freshly

g£own cells was then inoculated into a starter flask.

The

medium for the starter cultures was 100 ml of 2% (W/V) Vitaminfree Casitone {Difeo), which was dispensed into 250 ml
Erlenmeyer flasks and sterilized at 121
inoculation.

c

for 15 min prior to

Once inoculated, these flasks were incubated for

6 to 8 hr at 37 C on a rotary shaker.

The use of freshly grown

-obtain growth of the culture in the medium within this time
period.
The growth medium was inoculated with 1 ml of inoculum
from the starter culture medium (Vitamin-free Casitone).

The

flasks were then incubated for 17 hr at 37 C on a rotary
shaker {New Brunswick Scientific Co., New Brunswick, N.J.)
at 240 rev/min.

The cells were harvested, usually near the

end of the log phase (17 hr) by centrifugation at 4 C in
250 ml centrifuge bottles (IEC} at 30,000 x g for 15 min.
The cell pellet was collected, washed twice with 0.8% saline
and then used for the experiments.

L
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To inoculate the synthetic medium, the cells from the
starter culture medium were first centrifuged at 30,000 x

g for 10 min, washed twice with sterile 0.8% saline, adjusted
to the standard optical density, 1500 Klett units;

(a 1:10

dilution reads 150 Klett units) and then one ml was transferred
to the synthetic medium.

The flasks were then incubated for 17

hr at 37 C.
Growth measurements.

Growth was determined by measuring

the turbidity of the culture in nephelometer flasks with a
Klett-Summerson Colorimeter provided with a 600 nm filter.
Sterile Vitamin-free Casitone or.synthetic medium
a blank.

w;::ic::

nc::p(l

;::ac::

The nephelometer flasks were 300 ml Erlenmeyer flasks

with a side arm tube attached to the flask.

The flask did not

contain more than 100 ml of the medium and were exclusively
used for the measurement of growth.

The turbidity measurements

were performed rapidly so as to provide minimum exposure of
the cells to environmental changes.

All the experiments were

run in duplicate flasks and the values are the average of two
separate experiments.

When the difference in turbidity

readings between duplicate samples was greater than 25%, the
results of the experiment were rejected.

L
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Vitamin contents of the media.

2% Vitamin-free Casitone

medium contained following concentrations of niacin and
thiamine, based on information provided to us by Difeo
Laboratories:
Niacin.......

0.013 µg/ml

Thiamine .••••

<0.00013 µg/ml

Determination of glucose catabolic pathways.
a.

Radioisotope experiment.

At the end of 17 hr

of incubation the cells were harvested by centrifugation at
30,000 x g for 10 min at 4 C, washed twice and suspended in

was then adjusted with buffer to the same turbidity (180
Klett units using a 1:10 dilution) using a 600 nm filter.
A 1:10 dilution of this.heavy cell susoension that gave a
reading of 180 Klett units was approximately equal to 3 mg
dry weight/ml, an amount which was sufficient for the
experiments.
Metabolic flasks inoculation.

Radioisotope experiments

using labelled glucose were performed according to the method
described by Goldman and Blumenthal (35).

l

(SO ml) fitted with a center well
throughout the experiments.

Erlenmeyer flasks

(metabolic flask) were used

The center well was capable of

holding a small vial which contained a pa?erwick and also kept

•
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the vial isolated from the surrounding medium.
Employing a 1 ml long tip pipet, 0.5 ml of 0.5 M glucose1-14c was added to the main comoartrnent of each of the two
flasks.

Similarly, glucose-6-14c of same concentration (O.S M)

was added to the two additional flasks.

One ml of 0.1

~

(pH 7.0) potassium phosphate buffer was then added to the main
compartment of all flasks using a 5 ml long tip pipet.

For

each metabolic flask in the experiment; two serological tubes
were prepared containing 2.5 ml of 10% (V/V) perchloric acid.
These were used for quantitative determination of glucose in
the supernatant fluid.

Using a 10 ml pipet, 2.5 ml of the

-of each of the series of flasks at one min intervals.

During

each one min interval zero hour samples were removed for
glucose as follows:

the glucose-bacterial suspension in the

flask was well mixed for 10 to 15 sec, and then a 0.5 ml

sa~ole

was removed using a separate 1 ml long tip pipet for each
flask, and added to a serological tube containing perchloric
acid.

Following the removal of the zero hour sample, a small

glass vial containing a folded piece of Whatman No. 1 filter
paper (to increase

co 2

well using a forcep.

absorption) was added to the center
Each flask was immediately sealed with a

ser-um stopper and was incubated in a Dubnof f metabolic shaKer

L
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at

c.
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The flasks were shaken at about 100 cycles/min

for 120 min.
After all of the flasks had been started, a 1 ml
'syringe with a long 22 gauge needle was used to inoculate
1 ml of the C02 absorbing solution into each vial previously

p-laced in the center well.
~·

"e~hanoJ.amine

ethylene

This s.olution consisted of

glycol monomethylether of the

.fo-1-lowing composition (51):

ethanolamine - ethyleneglycol

:mon0methylether (1 :2 V/V).
l..iqu.id scintillation counting of

~-:r

~·.

14co2.

When the in-

:cubat.i:on period was over, the flasks were removed from the
~ker

in the same order as they were put into the water

~n.

:Ylben the flask was removed, the serum stopper was

::t'a..en nf:f, and the entire center well vial with its con-:E-~:tt-s
~;~

f:t:rapped

co 2 , co 2

absorbing solution and the paper)

carefull7 added to a 20 ml scintillation vial, of low

·-;::-~':::l:~~:..iJlm ~ontent

(Packard Instrument Co.) •

At the srune

· · ,_. · S nl 'Jf sample from the main compartment of the
·.c~-::~·~~~l -'.~ J'~oved
•· · · ~::-. •

~1 r:.lj

for analysis of glucose remaining in the

tJr]ded to the second serological tube containing

~~intillation
~ <

'"'1

. r.

1I f

•

I

vial, containing a center vial,

Ml of a mixture of toluene, ethylene-

..
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glycolmonomethylether, 2,5-diphenyloxazole (PPO)

(1:2:0.181

V/V/W} as scintillator and 1 ml of ethanolamine-ethyleneglycol monomthylether.

A background scintillation vial was

included in the experiments which consisted of non-incubated
center well vial with a filter paper and a scintillation
mixture of the same composition which was used to count the
samples.

Plastic screw caps lined with tin foil were then

carefully placed on the scintillation vial.

All of the

vials were well mixed, cleaned on the outside, and then
placed in Packard Tricarb Scintillation Spectrometer Model

# 3320, for counting.

All the vials, which were cooled

for 6 to 8 hr before the counting started, were counted at
least 3 -times.

The system had a counting efficiency of

approximately 80% for 14c.
Determination~of·glucose

utilization.

The serological

tubes containing bacterial-glucose suspension were centrifuged at 30,000 X g for 15 min.

Following the removal of

bacterial cells, glucose was determined by the anthrone
method of

Seifter et al.
b.

catabolism.

( 106).

Estimation of the pathways of glucose
The pathways of glucose catabolism were esti-

mated using the basic mathematical formulae devised by
Wang et al.
( 5) •

L

(119) and as modified slightly by Blumenthal
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From the information of the amount of radioactive 14co 2
yield from glucose-1-14c and -6-14c along with the quantity
of glucose (-1-C and -6-C) metabolized, determined by the
anthrone method, the percentage of HMP and EM were calculated
using the following formulae.

The percentage of 14co2

yielded by glucose-6-14c is a rough estimation of the extent of the operation of the TCA cycle.

HMP

=

x 100
GT

where

G1
,..

=

11,- .~

-o

%EM

14co

2 coming from glucose-1-+4c

\..V2

COlll.J..fl.9

irom

glu~ose-o-

,- "

'-

(cpm)
\ '-!;'lll i

=

Total amount of glucose labelled
utilized by cells during incubation.

=

100 - %HMP

Phosphate buffer-glucose medium.

In order to study the

effects of niacin or niacin analogs under resting cell conditions, buffered glucose medium, devoid of any nitrogen
source, was prepared by dissolving glucose in 0.05 M potassium phosphate buffer, pH 7.0, to yield e final concentration of 50 µmoles/ml.

The medium was sterilized by

autoclaving at 121 C for 10 min.

Niacin, thiamine or

niacin analogs were added to this medium under aseptic
conditions.

Washed cells, previously grown in Vitamin-free

r
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~.

casitone (VFC) or VFC containing niacin or niacin and thiamine
were inoculated in this medium and incubated at 37 C for 2 to
3 hr.

The incubated cells were then used either for isotope

experiment or for enzyme analyses.
Enzyme analyses of
a.

s.

aureus.

Preparation of cells for enzyme extraction.

Levels of glucose-6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD) and of other enzymes from
the HMP pathway and the level of isocitrate dehydrogenase
(ICD) from-the TCA cycle, were investigated.

Staphylococcal

cells were grown in Vitamin-free Casitone or in synthetic
medium alone or in the presence of the vitamjns.

- phase, ordinarily 17 hr.

All cultures

This period of growth was necessary

because high cell densities were needed in order to obtain
sufficient amounts of cells.
At the end of the growth period, the staphylococci
were harvested by centrifugation at 30,000 x g for 15 min
using a refrigerated centrifuge (International Equipment
Co., Model B-20) at 4

c.

The supernatant fluid was care•
fully discarded and the cells were then washed twice with
0.8% saline.

The cell pellet (ca. 1 g weight

) was then

suspended in approximately four volumes of 0.01 M tris
(hydroxymethyl)-aminomethane (tris) buffer, pH 7.5, containing 0.0001 M EDTA (ethylenediamine tetraacetic acid).
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The suspension was vigorously mixed with a vortex mixer

~nd

then subjected to sonic treatment in a 10 Kc Branson Sonic
oscillator (Model S-75) as follows.

A 3.8-cm (diameter)

solid step horn terminating in a 1.3-cm (diameter) irradiating
area (stainless steel) attached to 500 ml water jacketed
chamber was used for sonication of the cells.

The cell sus-

pension was cooled to 4 C prior to the treatment and was
subjected to sonic treatment for a total of 15 to 20 min.
The sonication was performed intermittently, never more than
40-50 sec at a time, and was followed by a 1-2 min period of
cooling in order to prevent a rise in temperature and loss
of enzymatic activity.

During the treatment time cooling

water (-10 C) was circulated through the jacketed chamber.
Treatment times longer than 20 min tend to result in loss
of enzyme activity of the extracts.

Sonic treatment of 17

min was found to be optimum for breakage of the staphylococcal cells.
After sonic treatment the mixture was centrifuged at
30,000 x g for 20 min at 4 C.

The supernatant fluid was

carefully decanted into a test tube, which was stored in an
ice bucket, and then used for the enzyme assay.
Before enzyme analysis, the protein concentration in the
crude extract was determined by the method of Waddell

(118).

This procedure of protein determination which depends on
the absorption of peptide bonds at 215 and 225 nm, has a
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greater sensitivity than the other methods and eliminates
the need for the addition of any reagents for color development.
b.

Protein determination.

A 0.02 to 0.04 ml

sarnole of crude extract was added to a quartz cuvette and
deionized distilled water was added to yield a final volume

of 1.5 ml.
water.

The blank cuvette contained deionized distilled

Absorbancy was recorded at 215 and 225 nm and the

difference of optical density (OD) was multiplied by the
factor of 144 and by the dilution factor.

This yielded the

final protein concentration in µg/ml of enzyme extract.
l-

,

I

'·, '

1

,

.:..:

•• •

~.·

'

·;

The crude extracts were stored at -15 C and showed very
little loss of activity of the enzymes studied, even after
storage for several months.
Reagents for the enzy:ne assay.

All the solutions were

made using doubly distilled, deionized water.
1.

NADP solution (3 µmoles/ml)
Dissolve 4.6 mg of NADP powder in 2 ml water

2.

NAD solution (3 µmoles/ml)
Dissolve 4.0 mg of NAD powder in 2 ml water

3.

Tris-HCl buffer (75 µmoles/ml)
Dissolve 0.09075 g of Tris (hydroxymethyl-aminomethane)
in 100 ml of water.

4.

L

Adjust the pH to 7.5 with 1 N HCl.

Manganese sulfate (30 µmoles/ml)
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Dissolve 0.830 g of

Mnso 4 ,

H2 o in water and make up

.

100 ml.
5.

Isocitrate (30 µmoles/ml)
Dissolve 7,75 mg of d-isocitrate-Na 2 in 1 ml water.

6.

Glucose-6-phosphate (30 µmoles/ml)
Dissolve 15.6 mg of glucose-6-phosphate-Na2 in 2 ml water.

7.

6-Phosphogluconate (30 µmoles/ml)
Dissolve 20.5 mg of 6-phosphogluconate-Na 2 in 2 ml water.

8.

NADH solution (1 µmole/ml)
Dissolve 3.4 mg in 5 ml 0.01 M Tris buffer, pH 8.0.

NADH

solution should be kept for no more than one week becaase
of the possible formation of an inhibitory factor.
9.

NADPH solution (1 µmole/ml)
Dissolve 4.2 mg in 5 ml of 0.01 m Tris buffer, pH 8.0.
Keep for no more than one week.

10.

KCN solution
Dissolve 1.3 mg in 10 ml water.

11.

AcPyAD solution
Dissolve 12.5 mg in 1 ml water.

12.

Glucose-6-phosphate dehydrogenase,

(G6PD)

(1 mg protein/

ml)
Dilute the stock solution with 2.2 M ammonium sulfate
solution.
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13.

Isocitrate dehydrogenase

(ICD)

(1 mg protein/ml)

Dilute the stock solution with 2.2 M ammonium sulfate
solution.
Enzyme assays.

All the enzyme assays were performed at

25 Con Gilford spectrophotometer, model 2000 (Gilford Instrurnent Laborat0ry, Oberlin, Ohio.) equipped with automatic recorder.

Standard 1.5 ml and 3.0 ml cuvettes (quartz)

with 1.0 cm light path were used.

Enzyme assays were

performed as described by Ragland et al.
a.

(96).

Assay for isocitrate dehydrogenase.·

The assay

of isocitrate dehydrogenase was based on the reduction of

Isocitrate

--------------+

NADP

a-ketoglutarate

NADPH

To a 1.5 ml cuvette the following solutions were added:

Tris

buffer 75 µmoles, Mnso 4 1.5 µmoles, isocitrate 3 µmoles,
deionized water 0.25 ml, extract 0.05 ml.
mination of initial absorbance

After the deter-

(at 340 nm), the reaction was

started by adding 0.15 µmoles of NADP and was followed by
recording absorbancy at 340 nm at 30 sec interval.

The

blank cuvette contained all the ingredients except NADP,
which was replaced by distilled water.
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b.

Assay for glucose-6-phosphate dehydrogenase.

glucose-6-phosphate
NADP

-------~

6-phosphogluconate
NADPH

The conditions for the assay of G6PD were the same as those
for ICD, except that isocitrate was replaced by glucose-6phosphate (3 µmoles/0.1 ml).
c.

Assay for 6-phosphogluconate dehydrogenase.

6-phosphogluconate --------~ ribulose-5-P + C02
NADP
NADPH
The conditions for the assay of G6PD were the same as those
for ICD, except that isocitrate was replaced by 6-phosphogluconate (3 µmoles/0.1 ml).
d.

Assay for transhydrogenase.

The transhydro-

genase assay was based on the reduction of AcPyAD.
NADPH + AcPyAD

NADP + AcPyADH

To a 1.5 ml cuvette the following solutions were added:
K2 HOP4, 75 µmoles; NADPH 2 , 0.45 µmoles; KCN, 1.5 µmole;
distilled water, 0.30 ml; and crude extract 0.05 ml.

After

the determination of the initial absorbance, the reaction
was started by addition of 0. 9 µmoles of_ AcPyAD and was
followed by recording at 30 sec intervals the absorbance
at 375 nm.

The blank cuvette contained all ingredients

except AcPyAD, which was replaced by distilled water.
e.

Assay for NADH and NADPH oxidase.

cuvette the following solutions were added:

To a 1.5 ml

K2 HP0 4 , 75

\
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µmole.s; NADH or NADPH, 0. 05 µmoles; and distilled water,
0.4 ml.

The reaction was started by adding 0.05 ml of

extract and was followed by observing the decrease in
absorbance at 340 nm.
Calculations.

All specific activities are expressed

as nanomoles of coenzyme reduced/mg of protein/min.

Specific activity

=

bE

x

v

10-6 x exd x mg of protein
in reaction mixture.
bE

=

change in absorbance/min.

V

=

volume of the reaction mixture in the cuvette.

E

=

.f!.xtinction ("'!()Pffj Ci Pnt Of thP "j l nht" 3~~nrhi l'HT cmt)Stance. (cm2/µmole) for NAD (340 nm) •. 6.22 x lOb
for AcPyAD (375 nm) •• 5.2 x 106

d

=

light path of cuvette (1 cm).

Uptake of niacin and its analogs.
a.
studies.

Preparation of staphylococcal cells for uptake

Staphylococci previously grown in unsupplemented

Vitamin-free Casitone were harvested by centrifugation, as
described previously.

These cells were washed three times

•
with sterile saline (0.09%) and then suspended in 0.01 M

potassium phosphate buffer (pH, 7.0) to yield a cell suspension of known concentration.

The concentration of the

cells was adjusted to a turbidity of 1500 Klett units

I
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(150 Klett units on a 1:10 dilution) using distilled water
as a blank.
b.
analogs.

Measurement of uptake of niacin and niacin

The incubation medium for the uptake studies was

of the following composition:
Potassium phosphate buffer, pH 7.0, 0.1 M .•
Glucose ( 1 %) •••••• ~ • • • • • • • • • • • • • • • • • • • • • • • •
Niacin or niacin analog (cone. variable) ..•
Washed cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1.-0
0. 5
1.0
2. 5

ml
ml.
ml
ml

The cell suspensions and the reaction mixture were
equilibrated at 37 C before mixing.

The reaction was started

by the addition of labelled niacin or labelled niacin analog.
Unless otherwise stated, the flasks were incubated at 37 C
-

the medium.

~

1.1... -

-· - ,

.,

-·

,.. -, !

I

'I

All incubations were carried out in duplicate and

the experiments were repeated at least once.

The concentrations

of niacin, quinolinic acid and of isoniazid that were used, are
listed in the respective tables of the results section.
The flasks were incubated for various intervals of time.
When the incubation had been completed, 0.2 ml samples were
rapidly withdrawn and filtered on membrane filters

(0.45 µ

pore size) that had been previously saturated with the
appropriate unlabelled substrate.

The cells which were

retained by the filter were quickly washed twice with 1 ml
deionized distilled water.

The filtrate and the membrane

filter containing the cells were added to separate 20 ml
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scintillation mixture to each vial, they were counted in a
liquid scintillation spectrometer.

When the difference in

counts between duplicate samples was greater than 25%, the
results of the experiment were rejected.
The scintillation mixture used for counting radio-a=tivity in the cells and in the filtrate was of following
composition:

p-dioxane, 900 ml; anisole, 150 ml; 1,2-

dimethoxyethane, 150 ml; PPO, 18g; and POPOP, 60 mg.
Among the factors that were included in the permeability
studies were the effects of time, temperature, pH and energy
source, competition between niacin and its analogs, and the
rat.e or f>"<'Ch<=maP of. ·1

c.
analogs.

<"I tie l ! Pd

n1 ;:,r.i:n,

Competition studies between niacin- and its

Competition studies between niacin and its analogs

were performed using radioactive niacin and either unlabelled
niacin or unlabelled analog.

The concentration of unlabelled

niacin or unlabelled analog (pyridine-N-oxide, isoniazid,
quinolinic acid, or 3-pyridylcarbinol) added to the incubation mixture, was 1000-fold higher than the concentration
of labelled niacin.
period

The reaction was carried out for 1 hr

after which 0.2 ml of samples were withdrawn for the

estimation of radioactivity within the cells and in the
supernatant fluid.
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d.

Measurement of exchange between intra- and·

extracellular niacin and its analogs.

In the experiment

involving exchange between accumulated radioactive niacin
and extracellular unlabelled niacin or the analogs,
staphylococcal cells were incubated in reaction mixture
containing niacin (2 µg/mJ), as described previously, for
60 min at 37

c.

During this incubation period the niacin

binding sites became saturated.

These niacin loaded cells

were collected by centrifugation at 30,000 xg for 15 min at
4 C.

They were washed twice with sterile 0.8% saline and

suspended in 0.05 M phosphate buffer,

described previously.

(pH 7.0).

The cell

Exchange reactions were initiated

by adding standardized cell suspension to incubation medium
from which labelled niacin was omitted and to which un.

.

labelled niacin (2 mg/ml) or one of the analogs (2 mg/ml)
was added.

After the desired intervals of time, samples

were removed and cellular radioactivity was determined.
Chemicals
Chemicals and enzymes.

The

chemica~s

and enzymes were

obtained from commercial sources and were not further
purified.

S-NAD (yeast), NADP (from yeast NAD), S-NADH

(grade III, yeast), NADPH (type III), AcPyAD (type I),
glucose-6-phosphate dehydrogenase (Zwischenfement, type V),
isocitrate dehydrogenase (type IV), chloramphenicol and
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puromycin were purchased from Sigma Chemical Co., St. Louis,
Mo.

The disodium salts of glucose-6-phosphate and isocitrate

were obtained from C. F. Boehringer, Mannheim, Germany.
Thiamine hydrochloride was obtained from J. T. Baker Chemical
Co., Phillipsburg, N.J., and niacin (nicotinic acid) from
Merck and Co., Rahway, N.J.

Anthrone was a product of

Nutritional Biochemical Corp., Cleveland, Ohio., and
actinomycin D was purchased from Mann Research Laboratories,
N.Y.

All other chemicals were reagent grade.
Chemicals for scintillation mixtures.

PPO (2,5-

diphenyloxazole}, anisole, 1,2-dimethoxyethane and ethanol
amine·were purchased from Eastman Organic Chemicals, Rochester
N. Y..

Ethy ler.u:9 lycol1uu.1.10nu:: t..hy le Lht:.1.. a.11d l:J-<l.i.o:Aa.wi: wc:i. i::

t.ained from Fisher Scientific Co., Fairlawn, N.J-.

u1.r

POPOP (1,

4-bis-(2-(5-phynyloxazolyl))-benzene was purchased from
Packard Instrument Co., Downers Grove, Ill.
Niacin analogs.

Nicotinuric acid, pyridine-3-sulfonic

acid and picolinic acid were obtained from Nutritional
Biochemical Co., Cleveland, Ohio.

The halogenated deriva-

tives of niacin, 5-fluoro-, and 5-chloronicotinic acid, and
5-fluoronicotinamide were gifts from Dr. F. Streightoff, Eli
Lily Co., Indianapolis, Ind.

Hydroxylated derivatives of

niacin, 2-hydroxy, 4-hydroxy and 5-hydroxyniacin were kindly
provided by Dr. O. N. Miller of Hoffman-La Roche, Nutley,
N.J.

All other niacin analogs were purchased from Aldrich

Chemical Co., Milwaukee, Wisconsin.
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Radiochemicals.

Niacin-7-14c was purchased from

Nuclear Chicago Corp., Des Plaines, Illinois, and had a
specific activity of 27.9 mCi/rnM.

Quinolinate-14c and

isoniazid- 14 c were purchased from G. D. Searle and Co.,
Des Plaines, Illinois, and had a specific activity of
43.7 mCi/rnM and 9.85 mCi/rnM, respectively.

Glucose labelled

on -6-14c and -1-14c were obtained from Volk Radiochemical
Co., Des Plaines, Illinois.

•

III.
A.

Growth of S.

aureu~

RESULTS
in Vitamin-free Casitone.

S. aureus requires niacin for growth, and both niacin
and thiamine are necessary for maximum growth stimulation.
A typical growth curve of S. aureus strain Towler, in 2%
Vitamin-free Casitone medium is shown in Fig. 1.

This

medium was chosen for the present studies because it contains
very low amounts of niacin and thiamine.
The results of the growth curve (Fig. 1) demonstrated
that there was only a moderate growth of staphylococci (i.e.,
72 Klett units) in the absence of any exogenous addition of

-traces of vitamins present in the medium.

The amounts of

vitamins present in 2% Vitamin-free Casitone are as follows:
0.013 µg/ml of niacin, and <0.00013 µg/ml of the thiamine
(Personal communication, Difeo Laboratories).

Addition of

thiamine (2 µg/ml) to the growth medium increased the amount
of growth only slightly above that in an unsup?lemented
control.

The addition of 2 µg/ml of niacin, however, in-

creased the turbidity readings from 72 to 250 Klett units
(24 hr).

This stimulation indicated that niacin was present

in limited concentrations for growth in the unsupplemented
growth medium.

Supplementation with both niacin and

thiamine resulted in maximal increase of the growth rate.
45
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Growth of S. aureus Towler, in 2% Vitaminfree Casitone with or without suoplementary
n1ac1n(2 ug/ml) ana/or thiamine(2 ~g/ml).
The growth, on rotary shaker at 37 C, was
followed by measuring the turbidity at 600 nn1.
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After 24 hr of incubation, the turbidity measurement reached
a maximum of 336 Klett units, as compared to 72 Klett units
in the unsupplemented Vitamin-free Casitone.

These results

demonstrated necessity for the presence of both vitamins for
maximal stimulation of staphylococcal growth.
B.

Analyses of the glucose catabolic pathways and of

enzyme levels.

(1)

Glucose catabolism in Vitamin-free Casitone

and in synthetic medium.
Table 1 shows the result of isotopic experiments
when vitamin supplements were added to a coagulase positive
.::.:lreu.:: strain Tm1lcr, · grown in

Casitone and in synthetic medium.

2~

-·----··---

TT.!

..L.

--~

,.,..

.C"'t-- r."\
_..;_,_,_

The results demonstrated

that staphylococci grown in unsupplemented 2% Vitamin-free
Casitone had a very low metabolic rate and a markedly
decreased utilization of the HMP pathway.

Approximately 5%

of the glucose was catabolized via the HMP pathway, while
the relative activity of the TCA cycle was less than 1%.
Addition of thiamine alone to the growth medium did not
stimulate the HMP cycle and resulted in only a small increase in the TCA cycle activity.

When the cells were grown

in a niacin-supplemented medium, however, they exhibited a
3- to 4-fold increase in the HMP pathway (i.e., from 5 to
22%) with a slight stimulation of the TCA cycle activity.
Supplementation with vitamins resulted in a 3-fold increase
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TABLE 1

Effect of niacin and thiamine on the glucose catabolic
pathways of Stanhylococcus aureus strain Towler

Addition (µg/ml) to
2% Vitamin-free Casi tone

% Glucosea
catabolized via
EM
HMP

None

95.0

5.0

0.9

Thiamine (2)

94.8

5.2

1.2

Niacin (2)

78.0

22.0

1.0

82. ('

1

g. ('

-1 • c:

Niacin (8)

67.0

33.0

2.0

Niacin ( 8) + Thiamine ( 4)

65.0

35.0

4.0

l.:rj :1("5

n {?)

-!-

r:r'h:i.nrr.4~~f?

(.,
\<f.

'

•

TCA cycle
activity (%)

Addition (µg/ml) to
synthetic medium

a Glucose catabolic pathways (EM and HMP) and the TCA cycle
activity were determined by the yield of 14co2 from
glucose-!- and -6-14c.
The values are the average of at least 3· determinations.
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Glucose utilization by s. aureus. Staphylococcal
cells were first grown in 2% Vitamin-free Casitone
with or without supplementary niacin, 2 µg/rnl,
and/or thiamine, 2 µg/ml.
The utilization of
glucose was determined under ~esting cell conditions
at indicated time by the method of Seifter et al ..
(106).
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in utilization of the HMP pathway and a 5-fold increase in
the activity of the TCA cycle.

For instance, the amounts of

glucose catabolized via the HMP pathway and the relative
activity of the TCA cycle were 18% and 4.5%, respectively.
These experiments indicated that niacin was
required for stimulation of the HMP pathway, while both
niacin and thiamine were necessary for the maximal operation
of the TCA cycle.

Increasing the concentration of the

vitamin in the medium from 2 to 10 µg/ml did not result in
any additional changes in the degree of utilization of the
different glycolytic pathways.
Htsult.& of E:Xpt:riments with cells grown l.Il syn-

- thetic media were more or less similar to the results
obtained with cells grown in Vitamin-free Casitone.

Since

staphylococci were unable to grow in synthetic media lacking
niacin, the isotope experiments were not done.

The amount

of glucose catabolized via the HMP pathway was approximately
30-35% in cells grown in the synthetic medium compared to
18-20% in cells grown in supplemented Vitamin-free Casitone.
The TCA cycle activity in the synthetic medium was increased
{2%), even in the absence of added thiamine.

However,

addition of thiamine to the niacin-containing synthetic
medium resulted in a 2-fold increase (4%) in the TCA cycle
activity.

This indicated that greater quantities of
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thiamine were needed for maximal operation of the TCA cycle
than were needed for the maximal operation of the HMP pathway.
(2)

Enzyme levels of the glycolytic pathways of

staphylococci previously grown in Vitamin-free Casitone and
in synthetic medium with or without vitamin suoplementation.
The growth of S. aureus was relatively poor in
unsupplemented Vitamin-free Casitone, and the relative
activities of the HMP pathway and the TCA cycle were also
low.

The addition of niacin or niacin and thiamine to the

growth medium not only stimulated growth maximally (Fig.l)
!.ru.~

..:1.lLo

inc:i::E::c..~e;:d

act.iviLi~.s

_by 4-fold (Table 1).

of the HMI' and Lllc.

TCl~

c~-.:.::

Analyses of some key enzymes of the

HMP pathway and of the TCA cycle under various conditions of
growth in both Vitamin-free Casitone and in synthetic media
were undertaken in an attempt to determine. if the increased
activities of the pathways were due to increased enzyme
synthesis.
When S. aureus was grown in Vitamin-free Casitone
medium (Table 2), the specific activities of G6PD ranged from
40 to 50 nmoles/mg protein/min, while the activity of 6PGD
and ICD varied between 15 to 25 nmoles/mg protein/min.

The

addition of thiamine alone resulted in only a slight increase
in ICD activity (from 15 to 21 units), while the activities
of G6PD, 6PGD and of other enzymes remained unaffected.

TAEL

~

2

Specific activities of enzymes fr Jn extracts of

s.

aureus grown in

variot:; media
Specific
Growth Medium

Glucose-6P-dehydrogenase

actii/~ty

6-Phosphogl uconate
de hydrogen :ue

of enzyme, nmoles/mg protein/min
Isocitratedehydrogenase

Transhy- NADPH
drogen- oxidase
ase

NADH
oxidase

Vitamin-free Casitone

49

23

15

12

3

12

Vitamin-free Casitone
+ niacin (2 µg/ml}

161
(20.5a)

37
( 2. 0}

22
(1.16)

14
( 0. 3)

6
(0.6)

(1. 4)

Vitamin-free Casi tone
+ thiamine (2 µg/ml)

48
( 0. 2)

20
(0.5)

21
(0.8)

7
(0.6)

(O.O)

16
( 0. 5)

Vitamin-free Casi tone
+ niacin and thiamine

153
(13. 7)

39
( 2. 7)

49
( 5. 6)

9·
( 0. 35)

8
( 0. 9)

19
(0.7)

3

25

Synthetic medium +
niacin (8 µg/ml)

75
(3.1)

20
( 0. 36)

16
(0.14)

(1. 6)

3
(. 0)

11
(0.13)

Synthetic medium +
niacin (8 µg/ml) and
thiamine (4 µg/ml)

98
( 5. 5)

30
(1.17)

28
(2 .1)

8
(0.57}

5
(0.63)

5
( 1. 8}

3

Enzyme activities were determined by the mett :J :I. of Ragland et al.

( 9 6) •

a Difference of mean by "t" test~ a value of 2.0 or greater is significant at the 5% level
or better.

~
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Following growth stimulation brought about by the addition
of niacin to the growth medium, however, there was a 3- to
4-fold increase in the

specif~c

activity of G6PD (from 49

to 161 units), with some increases in 6PGD, !CD and TH levels.
For instance, the specific activities·of 6PGD, !CD and TH in
niacin-grown cells were 37, 22 and 14 nmoles/mg protein/min,
respectively.
2-fold.

The NADH oxidase activity was elevated by

Similarly, addition of niacin and thiamine not only

stimulated G6PD synthesis but also increased ICD activity
from 15 to 49 nmoles/mg protein/min.

Generaillyr, the

activities of transhydrogenase, NADH oxidase and NADPH

The specific activities of G6PD, 6PGD and ICD in
supplemented 2% Vitamin-free Casitone was 153, 39 and 49
nmoles/mg protein/min,respectively, while in synthetic
medium it was 98, 30 and 28 nmoles/mg protein/min, respectively (Table 2).

Although there was 30 to 50% reduction

in the specific enzyme activities when the staphylococci
were grown in synthetic medium, the operation of the HMP
pathway in these cells was higher than in the cells grown in
supplemented Vitamin-free Casitone.
(3)

Glucose catabolic oathways and levels of some

dehydrogenases of different strains of S. aureus grown in
supplemented Vitamin-free Casitone.

In order to show that

the observation made on the Towler strain of S. aureus was

TABL~

3

Uniformity in effect of niacin and thiamine on the glucose catabolic pathways and on
some dehydrogenases of

Strain
Towler
18
23

z

Turbidity
(17 hr),
Klett units

staphyloco~~i

Glucose-6-Pa
de hydrogenase

6-P-glu:nnate det1 l drogena:; ·~

grown in Vitamin-free Casitone
Isocitrate
de hydrogenase

% HMPb

TCA cycleC
activity

340

153

39

49

18.1

5.2

310

149

32

51

18.5

4.3

331

160

28

44

.\ 9. 3

4.6

a

Specific activities are expressed as nanomoles/mg protein/min

b

% glucose catabolized via the HMP pathway a> determined by the yield of 14 co 2 from

glucose-1- and -6-14c.

c

Re la ti ve activity" of the TCA cycle as dete"::".'·lined by the yield of 14co2 from
glucose-6-14c.

r
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not

p~culi~r

to that strain alone, the glucose catabolic

pathways and the specific activities of G6PD and 6PDG from
the HMP pathway and of ICD from the TCA cycle were also
measured in other coagulase positive strains of staphylococci previously grown in supplemented Vitamin-free Casitone.
The results of these studies showed that the other coagulase
positive strains followed the same pattern as strain Towler.
For instance, addition of both vitamins to the growth medium
not only resulted in maximum growth (310 to 340 Klett units)
but also increased glucose utilization via the HMP pathway
and the TCA cycle activity to 19% and 4.5%,

~espectively.

tested were approximately 150, 32 and 45 nmoles/mg protein/
min, values similar to those obtained for the Towler strain.
Addition of vitamins to the growth medium stimulated growth maximally (340 Klett units) and increased the
HMP and the TCA cycle activities to 20% and 5%,respectively.
Along with the increases in the HMP pathway, the level of
G6PD was also tripled.

Thus there was a strong correlation
4

between the activities of the HMP enzymes and the degree of
operation of the HMP pathway.
(4)

Glucose catabolic pathways and enzyme levels

under resting cell conditions.

The effect of vitamins on the

glucose catabolic pathways was tested under resting cell

56
conditions and the results are shown in Table 4.

The data

from Table 4 (Expt.I) indicated that the incubation of
vitamin-deficient resting cells in buffered glucose resulted
in cells which oxidized glucose in a manner similar to that
of cells grown in the presence of the vitamins.

For instance,

when vitamin-deficient cells were incubated with the vitamins,
the amount of

~lucose

catabolized via the HMP pathway and the

relative activity of the TCA cycle were 18% and 5.6%, respectively, values similar to those of cells grown in the
presence of the vitamins.

These results indicated that the

vitamins stimulated these metabolic activities even in the

absAncA

~r

qrowtn.
The results of the enzyme analyses under resting

cell conditions are presented in Table 5.

The levels of G6PD

and 6PGD were not increased by the presence of niacin, even
though the HMP pathway activity was increased.

Similarly,

ICD activity remained low when both vitamins were added to
the medium.

For example, the specific activities of G6PD

and ICD were 43 and 15 nanomoles under resting cell conditions
compared to 153 and 49 nanomoles/mg protein/min when the cells
were grown in the presence of these vitamins.

In spite of the

low activities of G6PD and ICD (i.e., 43 and 15 units) under
resting cell conditions, there was a greater utilization of
glucose via both the HMP pathway and the TCA cycle.
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TABLE 4
Changes in the glucose catabolic pathways and in the TCA cycle
activity in the absence of growth by incubation of vitamindeficient S. aureus Towler suspensions with thiamine and/or
niacin

Expt.

1.

2.

Additions to the vitamin-deficient resting
cell suspensiona

TCA cycle
activity
( %}

% Glucose
catabolized via
EM
HMP

None
Thiamine, 4 µg/ml
Niacin, 8 µg/ml
Niacin and thiamine

0.2
1.2
0.6
5.6

92
92
79
82

21
18

Niacin (2 µg/ml} and
thiamine (2 µg/ml}

4.0

80

20

wi~h

] ' (l

84

I

Niacin (2 µg/ml} and
thiamine (2 µg/ml)
Chloramphenicol
(25 ·µg/ml}, plus niacin
and thiamine
Chloramohenicol (50
µg/ml), plus niacin
and thiamine

4.0

84

16

4.0

86

14

3.0

83

17

0.6
0.9
4.0

95
95

5
5

88

16

Ni?~in

~nrl

~~ia~1np

8
8

f.

chloramphenicol
c25 µg;in1>

3.

4.

a

None
Chloramphenicol(50µg/ml}
Chloramphenicol(lOO
µg/ml}, plus niacin
and thiamine

After growth for 17 hr in 2% Vitamin-free Casitone, the cells
were washed with and suspended in 0.05 M Na and K phosphate
buffer, pH 7.0, at twice their original concentration.
Glucose was added at a concentration of 50 µmoles/ml, and
the flasks were placed on a rotary shaker for 3 hr at 37 C.
These cells were then harvested and used in the usual manner.

TAF L !: 5
~bsence

Influence of the addition of vitamins, in the·

of growth, on some enzyme activities

of vitamin-deficient EU3pensions of
Specific
Addition to the
vitamin-deficient
s. aureus
None

Glucose-6-P
dehydrogcnase
42

-

activiti~s

s.

aureus

of enzymes, nmoles/mg protein/min

6-P-gJu:onate
dehyd1c~enase

Isocitrate
dehydrogenase

NADH
oxidase

12

12

6

2C

NADPH
oxidase
3

Niacin (2 µg/ml) +
thiamine ( 2 µg/ml)

43
(0 .19a)

( 0. 8)

15
( 0. 3)

8
( 0. 3)

5
(0.47)

Niacin + thiamine +
chloramphenicol (50)

44
( 0. 32)

13
(0.1)

16
(0.57)

9
(0.5)

4
(0.34)

Chloramphenicol ( 50)

40
(0.6)

;c
co. e>

17
(0.7)

10
(0.56)

5
(0.69)

Cells· were grown in 2% Vitamin-free Casitone f~r 17 hr, washed with, and suspended in
0.05 M Na and K phosphate buffer, pH 7.0, at t~ice their original concentration.
Glucose was added at a concentration of 50 µ~;oles/ml and after the indicated additions
were made the flasks were placed on a rotary Ehaker at 37 C for 3 hr. The cells were
then washed and the enzyme activities were determined in the crude extracts by the
method of Ragland et al. (96).
a

Difference of means by "t" .test; a value c.f 2.0 or more is
level or better.

signifi~ant

at the 5%

VI
00
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(5)

Changes in glucose catabolic pathways and.in

enzyme levels by the addition of vitamins in the absence of
protein synthesis.

To insure that protein synthesis was not

proceeding from the endogenous amino acid pool, vitamindeficient staphylococcal cells were incubated in a buffered
glucose medium containing niacin and thiamine (2 µg/ml,
each), and along with any of the following antibiotics:
puromycin, chloramphenicol, or actinomycin D.
The results of the experiments, presented in Table
6, were essentially the same as those reported in Table 4,
in that niacin and thiamine stimulated the HMP p·athway and
the TCA cycle activity (ca. 1.8% and 4%) even in the presence
of antibiotics.

The chloramphenicol control experiment

(Table 4, Expt. 4) in which the vitamins were omitted showed
that the antibiotic itself was not responsible for any of
the observed biochemical changes.

In the presence of

actinomycin D, over 30% of the glucose was catabolized via
the HMP pathway, following the addition of vitamins, a value
considerably higher than that reached in the absence of the
antibiotic
Analyses of enzyme activities again demonstrated ·
that (following the addition of the vitamins), the level of
G6PD was not significantly increased over the control value
(44 units, Table 5).

The specific activities of the other

enzymes also

less and variable.

re~ained

Effect of niacin and thiamine on some bioc:1cmical properties of vitamin-deficient

s.

aureus in the absence of protein synthesis

Vitamin-deficient res~ing cellsa incubated in buffered glur·~ose containing
niacin + thiamine ( 5 ·:9/ml) and:
Chloram- T'uroActinoNo
phenicol, ~ycin,
mycin D,
antibiotic 25 µg/ml ~ µg/ml
3 µg/ml
O Hr 3 Hr
3 Hr
3 Hr
3 Hr
Intact Cells·
% Glucose via HMP
Rel. act. of TCA

Resting cellsb
previously grown
on Vitamin-supplemented (5 µg/ml
niacin + thiamine)
medium

5.0

16.0

4.0

14.0
4.0

18.5
5.7

34.0
5.0

16 .·o

0.6

0.2

3.5

3.8

3.5

13.2

6.7

0.5

2.2

0.5

4.0

Cell Extracts
NAD, µmoles/g.
dry wt.
NADP, µmoles/g/
dry wt.
Glucose-6-P dehydrogenase, Sp. Act.

0.2

0.4

D.4

46.0

42.0

42.0

145.0

Isocitrate de hydrogenase, Sp. Act.

22.0

13.0

16,0

58.0

a

Cells were grown for 17 hr in unsupplemen;.:ed 2% Vitamin-fre~ Casitone, harvested,
washed with saline, and suspended in 0.05. t! phosphate buffet, pH 7.0, containing
0.9% glucose, niacin and thiamine.

b

Cells were grown for 17 hr in 2% Vitamin-·:ree Casitone containing niacin and
thiamine, and suspended in 0. 05 M phospha-.:E buffer, pH 7. 0, with no vitamins.
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Since the addition of the vitamins under resting
cell conditions did not significantly increase the specific
activities of the enzymes tested, and since the use of antibiotics precluded protein synthesis, new enzyme synthesis
as a possible explanation for the increased activity of the
HMP pathway has been eliminated in the present studies.
Parallel experiments in this laboratory have
demonstrated that when the vitamin-deficient resting cells
were incubated with antibiotics for 3 hr with either niacin
or niacin and thiamine, the NAD and NADP levels increased
10- and 2-fold, respectively (44).
(6)
pathways of

s.

Tl?-~.. ~!-~~ct_ <?,~---~!-~EY:~tion on qlucose cata,bo~ic

aureus.

Results of the previous experiments

(Table 4) indicate that increased enzyme levels were not
responsible for the increased operation of the HMP pathway
following ~ddition of niacin.

Sine~ there were 10- and

2-fold increases in the NAD and

NAD~

levels, respectively,

along with increased activity of the HMP cycle, it is likely
that one of the coenzymes regulated the HMP pathway activity
of S. aureus in some manner.

Since the .NAD content in

E. coli has been found to decrease during a period of
incubation in buffered glucose (86), experiments were
therefore designed to determine whether such a variation
in NAD could be observed in staphylococci during starvation
and, if so, to correlate the NAD and NADP levels with the
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degree of utilization of the EM and HMP pathways.
Fig. 3 presents the results of the glucose catabolic
pathways during starvation of staphylococcal cells previously
grown in Vitamin-free Casitohe supplemented with 0.5 µg/ml
of niacin and 2.0 µg/ml of thiamine.

This niacin level was

selected to yield cells with a high level of glucose oxidation
via the HMP pathway, but with levels of NAD that

we~~

not high.

The results of nicotinamide coenzymes are included for the
purpose of comparison (Fig. 3).
During the 2 hr period of starvation the operation
of the HMP pathway was reduced from 18.5% to 10%.

Similarly,

a 50% reduction in NAD content was observed (i.e., 2.3 to
1. 2 micromoles/g dry weight).

Throughout the incubation

period the level "of NADP was not reduced and remai:neciover;
•1-

0.4 micromoles/g.

...

There was no further decline in the HMP

pathway as the incubation continued.

The amount of glucose

catabolized via the HMP cycle was approximately 9.8% after
4 and 6 hr of starvation, compared to 18.5% before starvation.
Further reduction in NAD content from 1.0 to 0.6 micromoles/g
was noted, and this level remained unchanged as the incubation continued.

The level of NADP did not decrease but

rather increased as the incubation period continued up to
6 hr.

Throughout the period of starvation the activity of

TCA cycle decreased slightly but was still quite active.
Thus, the TCA cycle activity at O, 2, 4 and 6 hr was 4.5,
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Biochemical changes in s. aureus during i~c~~ation
in buffered glucose.
Cells were gro~n for 17 hr
in 2% Vitamin-free Casitone suoplemented ~i~h
0. 25 µg/ml niacin and 4 µg/ml thiamine, '.·:as'.':ed
with saline and incubated in 0.05 MK phos?hate
buffer, pH 7.0, containing glucose. At intervals
samples were removed for the analyses of glucose
catabolic pathways in a manner previously
described (see Methods).
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4.0, 3.8 and 3.0 percents, respectively.
At the end of the 6 hr incubation period niacin

(100 µg/ml) was added to the buffered glucose medium and the
incubation was continued for another 2 hr.

Following this

procedure, the operation of the HMP pathway increased from

10% to 19% while the NAD rontent was increased to 1.3
µmoles/g dry weight.
0.7 µmoles/g.

The NADP content also rose from 0.6 to

On the basis of these findings it is evident

that for staphylococci, NAD levels above (approximately) 1.5
µmoles/g were necessary for the operation of the HMP pathway
at levels above 20%.
r

Stndiec
(1)

~ith

nia~jn

anaJoqs

Growth curve of

s.

aureus in Vitamin-free

Casitone in the presence of niacin analogs.

The results of

preliminary studies on the effect of several niacin analogs
on the growth of S. aureus, Towler, in
are presented in Fig. 4 and 5.

Vitamin~free

Casitone

In Vitamin-free Casitone

(Fig. 4) the small amount of growth (turbidity of 70 Klett
units) tripled upon the addition of niacin.

When niacin was

replaced by niacin analogs in concentrations ranging from
100 to 1000 µg/ml, there was a moderate increase in growth.
For instance, none of the analogs produced turbidity
readings over 150 Klett units in 24 hr of incubation in
comparison to the 250 Klett units produced in the presence
of niacin.

In the presence of thiamine (Fig. 5), however,

•
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Growth of s. aureus in 2% Vitamin-free Casitone
with added analogs of niacin. Experimental
conditions were same as in Fig.l. N=niacin,
2 µg/ml; NNO=nicotinamide-N-oxide, 100 ~g/~l;
NDA=nicotinyldiethylamide, 100 µg/ml;
3-AP=3-acetylpyridine, 1000 µg/ml; C=unsupplemented Vitamin-free Casitone.
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thiamine. Experimental conditions were
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all the analogs tested with the exception of 6-HN and 6-AN
produced approximately the same stimulation as the addition
of niacin and thiamine.

For example, when nicotinamide-N-

oxide (NNO), thionicotinamide (ThN), or 3-acetylpyridine (3AP)
were added to a thiamine supplemented growth medium, the
turbidity measurement reached a maximum of 330 to 360 Klett
units.
Data from Fig. 4 and 5 indidated that the concentration of niacin analogs required for the maximal stimulation
·,~

of growth was approximately 100- to 1000-fold hi_gher than that
of niacin.

The use of 3-acetylpyridine or pyridine-3-sulfonic

and Table 13).

Necessary concentrations of other pyridine

derivatives varied somewhat from 100 to 500 µg/ml in order
to support full staphylococcal growth when added to the
Vitamin-free Casitone medium with added thiamine.
In addition, results of these growth curve studies
demonstrated no lag in the growth in the presence of niacin
analogs.

The duration of the observed lag period was similar

to that produced when niacin was added to the growth medium.
This indicated that the growth-stimulating effect of the
addition of analogs was not due to selection of mutants
capable of using analogs.
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(2)

Growth of S. aureus in synthetic meditim in the

presence of niacin analogs.

Since Vitamin-free Casitone

contains small and variable amounts of niacin and thiamine,
the effect of the niacin analogs on S. aureus growth in
completely synthetic medium was investigated.
of these studies are presented in Table 7.

The results

The findings of

these experiments showed practically no growth of staphylococci in the absence of either niacin or niacin and thi'arnine.
A turbidity reading of 55 Klett units was obtained when
niacin alone was present in the synthetic medium, while growth
reached a turbidity of 270 Klett units {48 hr) when both

niacin analogs in the medium lacking thiamine,
somewhat from 11 to 40 Klett units.

g~owth

varied

Data in Table 7 shows

that, of all pyridine derivatives tested, nicotinamide-Noxide, thionicotinamide and nicotinuric acid yielded maximal
growth stimulation (i.e., 270 to 343 Klett units) in synthetic
'medium with added thiamine.

There was very little growth when

6-hydroxynicotinic acid or 6-aminonicotinamide was added to a
thiamine-supplemented synthetic medium. · Higher yield of cells
obtained upon addition of nicotinamide-N-oxide, thionicotinamide or pyridine-3-aldehyde to the growth medium indicates
that these analogs could be used more effectively than niacin
in stimulating growth of staphylococci.
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TABLE 7

s.

Effect of niacin analogs on the growth of

aureus in a

synthetic medium
compounds tested

Concn
µg/ml

Synthetic medium

Synthetic medium
+ thiamine
Turbiditya in Klett units1 after
24 hr
48 hr
24 hr 48 hr
2

6

5

15

8

55

54

239

270

Nicotinarnide-Noxide

100

16

28

293

343

Thionicotinarnide

500

15

28

254

315

Nicotinuric acid

8

9

28

226

271

1000

5

11

100

13

107

150

None
Niacin

~·

}..cetylpyridine

Nicotinyldiethylamide

24
'

Pyridine-3-sulfonic
acid

250.

6-Hydroxynicotinic
acid
6-Arninonicotinarnide

a

'-~

'•

~

·26

40

195

110

500

2

6

7

15

100

3

3

4

10

Turbidity measurements were made at 600 nm.
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(3)
~rains

Effect of niacin analogs on growth of different

of staphylococci and Gram negative bacteria in

~nthetic

medium supplementeq with thiamine.

To insure that

niacin analogs replaced niacin in more than one strain of

s.

aureus additional strains of

s.

aureus,

s.

epidermidis and

a few niacin requiring Gram negative bacteria were tested.
The results of these growth studies are shown in Table 8.
The data indicate that 3-acetylpyridine and nicotinyldiethylamide could reproduce the effect of niacin on the growth of
these organisms.

Although the response of the organisms

varied somewhat, growth stimulation was noted in all the

(1000 µg/ml) or nicotinyldiethylamide (100 µg/ml) was added
to a thiamine-supplemented synthetic medium, the growth of
tested strains of

s.

aureus and

s.

epidermidis was stimulated

(over 150 Klett units), and the cell yields were similar to
those obtained following the addition of niacin and thiamine
to the synthetic medium.

The data also indicates that

niacin-requiring S. dysenteriae, P. vulgaris and P. morgani
successfully used either 3-acetylpyridine or nicotinyldiethylamide for growth stimulation.
(4)

Effect of niacin analogs on the glucose

catabolic pathways of

s.

aureus.

Preliminary experiments

(Table 1) had shown that addition of niacin and thiamine to

.··~

TABLE 8
Growth of staphylococci and of Gram negative l:·acteria in a thiamine-supplemented synthetic
medium with niaci:r: or niacin analogs
Niacin or niacin analogs added to the synthetic medium
Niacin,
8 µg/ml

Strain

3-Acetylpyridine,
1000 µg/ml

Nicotinyldiethylamide,
100 µg/ml

~~~~~~~~~~~~~~~~~~~~~~~

Turbidity in Klett units after 24 and 48 hr

s.

aureus

24 hr

Towler
3
10
18Z
Serotype I
Serotype I I I
Serotype IV

s.

epidermidis

155
12228
14990
Shigella f lexneri
Proteus morgani
Proteus vulgaris

•

48 hr

24 hr

48 hr

24 hr

48 hr

239
92
229
228
276
242
155

270
185
264
270
274
282
.264

134
171
184
166
189
192
215

205
168
176
228
183
257
224

107
30
89
41
131
221
174

150
170
93
168
173
271
225

117
212
220

228
212
215

llC
189
191

234
199
272

44
63
172

160
155
180

145
210
221

137

12i.

117

103

115

200

20;

209

183

159

195

17~··

182

186

167

Synthetic medium was devoid of nicotinic acid.
Turbidity measurements were made at 600 nm; t.he values are the average of two separate
experiments.

.t
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the growth medium had considerable influence on the metabolic
activities of S. aureus.

Therefore, the effect of niacin

analogs on glucose catabolic pathways of staphylococcal
cells was investigated.

The results of measurements of

the glycolytic pathways of S. aureus grown in 2% Vitaminfree Casitone with added niacin analogs and thiamine are
shown in Table 9.

Those compounds which were highly active

are included in this table.

Approximately 18% of the

glucose was metabolized via the HMP pathway when niacin
and thiamine were added to the medium.

All of the analogs

listed in Table 9, except 6-hydroxynicotinic·acid and
6-aminonicotinamide, produced similar increases in the HMP
pathway utilization and in the TCA cycle activity. For
instance, when niacin analogs and thiamine were added to
the growth medium, the amount of glucose catabolized via
the HMP pathway ranged from 15 to

24~,

and the relative

activity of the TCA cycle was 4.5 to 7.0%, as compared to
4.5 when niacin and thiamine were added to the growth medium.
The data also show that the concentrations of the
•

analogs required to stimulate the HMP pathway were 100- to
1000-fold higher thah that of niacin.

As shown in Table 9,

when nicotinamide-N-oxide (100 µg/ml) and 3-acetylpyridine
(1000 µg/ml) were added to the growth medium, about 15% and
18.7% of the glucose was oxidized via the HMP pathway,

r
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TABLE 9
Effect of niacin analogs on the glucose catabolic pathways and
on caenzyme levels of S. aureus
Addition {µg/ml) to
Vit.-free Casi tone

% Glucose

via HMP

Rel. Act.
of TCA {%)

Concn ofa
NADP
NAD

None

5.0

0.2

0.3

0.2

Thiamine {4)

5.2

1.2

0.4

0.2

Niacin {8)

22.0

4.5

4.8

0.6

Niacin {8) + thiamine (4)

18.0

4.5

3.5

0.4

nicotinuric acid (8) +
thiamine (4)

19.9

6.1

2.7

0.4

Nicotinamide-N-oxide (100)

15.1

7.4·

3.0

0.4

3-Acetylpyridine (1000) +
thiamine (4)

18.7

5.2

0.4

0.1

Nicatinyldiethylamide (100)
+ thiamine (4)

18.3

5.1

1.0

0.2

7.8

3.7

0.4

0.3

24.2

4.6

3.2

0.6

'

1..iL_cu11~i..c

f'

\ '"t

J

6-Hydroxynicotinic·acid (500)
+ thiamine (4)
3-Pyridylcarbinol (100)
+ thiamine ( 4)
%

a

Glucose catabolized via the EM and the HMP pathway and the
relative activity of TCA cycle were estimated as described
previously (see Methods).
Nicotinamide coenz0nes values are expressed in µmoles/g
dry weight.
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respectively.
These readings indicate that niacin analogs could
replace niacin for stimulation of glucose utilization via
the HMP pathway in

s.

aureus.

The results of these

.

experiments also indicate that addition of 6-hydroxynicotinic acid to the growth medium did not increase the activity
of the HMP pathway, although it caused significant changes
in the TCA cycle activity.

Due to these unexpected results

6-hydroxynicotinic acid was further investigated; the results
of the experiments are presented in Table 15 of this section.
Since earlier experiments suggested that some of the
niacin analogs could completely replace niacin for stimulatiori of staphylococcal growth and could also increase
glucose utilization via the HMP pathway, additional pyridine
derivatives were investigated.

On the basis of the results

on growth and on the HMP pathway utilization of

~·

aureus,

the niacin analogs have been classified into 4 groups:

the

results are presented in Table 10 with the chemical structure
of all the compounds shown.
D.

Classification of niacin analogs
Group I.

pathway maximally.

Analogs stimulating growth and the HMP
In this category 25 analogs that

maximally stimulated HMP pathway utilization and growth in
2% Vitamin-free Casitone suppliemented with thiamine are

75
included.

For instance, growth reached a turbidity of 340

to 360 Klett units while the amount of glucose oxidized
via the HMP pathway was 15 to 23%.
Group II.

Analogs allowing partial stimulation.

of growth and of HMP pathway activity.
the following analogs are included:

In this category

3-pyridylacetic acid,

3-ethylpyridine, 6-chloronicotinamide, dipicolinic acid,.
picolinic acid, 2-aminonicotinic acid, pyridine-2 and
-4-aldehyde and 2-chloronicotinic acid.

It can be seen

that most of these analogs were substituted at the 2-,
4- and 6-positions of the pyridine ring.

All of these

pyridine derivatives partially stimulated growth and HMP
pathway activity.

For example, growth did not exceed a

turbidity of 160 to 180 Klett units, and the amount of
glucose utilized via the HMP pathway ranged from 10 to 14%
in the cells grown in a thiamine supplemented Vitamin-free
Casitone.

Most of the analogs were tested at 3 or 4

different concentrations. Even when the concentration of
these analogs was increaed to 5000 µg/ml, there was neither
increase in the amount of growth nor in the utilization of
•
the HMP pathway.
Group III.·

Analogs having no effect on either

growth or on the HMP pathway.

This category included

4-acetylpyidine, 3-benzoylpyridine, pyridine, pyridoxine,
2,6-diacetylpyridine, 3,4-diaminopyridine, 2-picoline,

..
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4-picoline, 3-hydroxypyridine-N-oxide and other pyridine
derivatives (Table 10).

The analogs were tested using a

wide range of concentrations and the results showed that
the addition of these analogs to a thiamine-supplemented
Vitamin-free Casitone did not increase the growth over the
control level (70 Klett units).

Similarly, increase in

glucose oxidation via the HMP pathway was not observed.
For instance, staphylococcal growth reached a turbidity of
only 60 to 70 Klett units, the same as unsupplemented media,
and the level of HMP pathway activity remained at 6-8%.
Group IV.

Analogs with complete inhibition

3-hydroxypicolinic acid, 5-fluoronicotinamide and
pyrizinamide.

The addition of these analogs to the growth

medium resulted .in complete inhibition of staphylococcal
growth.
E.

Correlation between growth and the glycolytic

pathways.
(1)

Influence of niacin and niacin analog
•

concentrations on growth and on the glycolytic pathways
of S. aureus.

The results of a number of experiments

have suggested that growth stimulation and stimulation of
the HMP pathway activity are independent of each other.
This was first clearly demonstrated in studies with
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TABLE 10
The ability of various pyridine derivatives to replace niacin for
staphylococcal growth and for .the stimulation of the HMP pathway
activity and NAD concentration.
Stimulation of
HMP
activity

NAD
con en

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

Isoniazid
(isonicotinylhydrazide)

+ +

+ +

+ +

Isonicotinic acid

+ +

+ +

+ +

Structure

compound

Growth

Group I
Nicotinic acid
(niacin)

Nicotinamide
.
.
.~

~'

\u... ct(.;..i...L1c:U.ll.J..Uc J

Nicotinic acidN-oxide

Ethylnicotinate

COOH

@g-C2Hs

~··

78
Table 10 (Continued)
Stimulation of
compound

Structure

Growth

rsonicotinamide

HMP
activity

NAD
concn

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

T

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

_g_NH2

Nicotinamide-Noxide
0

N- i.·ic U1y 111..i.co lir,1a.•·

mide·

@8-1m

2

+

6H3
N-Ethylnicotinamide

Thionicotinamide

Nicotinuric acid
(nicotinyl glycine)

g-NH2

r
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Table 10 (Continued)
Stimulation of
Structure

compound

NicotinyldiethylaTllide (coramine)

Pyridine-3-sulfonic
acid

..."'

~:._vl:;.A.~·

. IJ-,. ~~i;.l~

HMP
activity

NAD
concn

+

+ +

+ +

+ +

+ +

+ +

Growth

@ ,CH2CH3
-C-N,,_

CH~CH3+

@~-OH

@
@-CH3

-CH3

y

·"i

.

.

I

0

3-Picoline-N-oxide

+ +

+ +

+ +

Pyridine-N-oxide

+ +

+ +

+ +

- 3-Acetylpyridine

+ +

+ +

+ +

d

80

Table 10 (Continued}
Stimulation of
compound

Structure

Growth

HMP

activity

NAO
concn

pyridine-3-aldehyde

+ +

+ +

+ +

4-Pyridylcarbinol

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+ +

+

+ +

- +

3-Pyridylcarbinol

rOrCH20H
~·

3-Pyridylcarbinol-Noxide

@CH20H
.a,

0

Quinolinic acid

@COOH
COOH

•
5-Chloronicotinic
acid

Cl-@-COOH
-0

+ +
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Table 10 (Continued)
Stimulation of
Structure

compound

Group I I

Growth

HMP
activity

NAD
concn

2-Chloronicotinic
acid

~COOH
~Cl

+

+

2-Aminonicotinic
acid

@COOH

+

+

ND

+

+

+

+

+

+

+

+

+

+

+

+

NH2

(S)"Cl12COO'.'.
..........

3-Pyridylacetic
acid

Picolinic acid

Dipicolinic acid

@COOH

HOOC-~COOH

Pyridine-2-aldehyde

@~-H

-·
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Table 10 (Continued)
Stimulation of
Structure

compound

Growth

F~·!P

activity

+

Pyridine-4-aldehyde

6-Chloronicotinamide

:'.:-IAD

con en

~~-NH2
Cl-~

. .

..,, .,.., ' ,_ - - , - . . .,
- ----.,,1.-.a:..1.~---·--

Group I I I
3-Benzoylpyridine

+

+

.,

@_g_@

ND

NH2

3,4-Diaminopyridine

3-Hydroxypyridine-Noxide

@-NH2

@-OH
I

0

ND

..,.,

r
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Table 10 (Continued)
Stimulation of
Structure

compound

2,4-Pyridinedicarboxylic acid

-COOH

pyridine

Growth

HMP
activity

NAD
concn

ND

©

O=<f-CH3

fol

4-Acetvlpyridine

ND

J

·~

CH20H

Pyridoxine

6-Hydroxynicotinic
acid

5-Fluoronicotinic
acid

HO-©-CH20H
H3C-

_

©-COOH
HO-

F-©-COOH

ND

r
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Table 1-0(Continued}
Stimulation of
compound

Structure

Growth

HMP

activity

2-Hydroxynicotinic
acid

~lcooH

NAD
concn

. ND

~OH

4-Hydroxynicotinic
acid

ND

2-Picoline

4-Picoline

Group IV
6-Aminonicotinamide

@)8-NH2
H2N-

3-Hydroxypicolinic
acid

@OH

COOH

•

i

i

i

ND

ND
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Table 10 (Continued)
Stimulation of
Structure

compound

Growth

activity

NAD
concn

HMP

5-Fluoronicotinamide

i

ND

ND

Pyrizinamide

i

ND

ND

Symbols:

+ +,
+,
,
i,
ND,

Maximal stimulation
Partial stimulation
No stimulation
Inhibition
Not determined

•
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3-pyridylcarbinol (Table 11).

There appeared to be two

distinct effects of 3-pyridylcarbinol (3PC) which are
concentration-dependent. At a concentration of 2 µg/ml
growth was stimulated submaximally (147 Klett units)
while at a concentration of 10 µg/ml of 3PC turbidity
measurements reached 355 Klett units, indicating that
maximum growth had been reached.

Yet analyses of the

glucose catabolic pathways by cells grown with different
levels of 3PC (2 and 10 µg/ml)

in the medium showed that

only 7 to 9% of the glucose was catabolized via the HMP
pathway with partial stimulation of the TCA cycle activity
(l.2%). Thus, results trom Table ll indicate that concent-

rations of 10 and 50 µg/ml were sufficient to produce
maximum growth but not sufficient to stimulate the glycolytic pathways. A concentration of 100 µg/ml or more of 3PC,
however, was shown to increase both growth and the
utilization of the HMP pathway maximally in staphylococci.
It can be seen that along with the maximum growth the
amount of glucose oxidized via the HMP pathway and the
relative activity of the TCA cycle were 27.0% and 3.7%,
repsectively. When a concentration of 5000 µg/ml of 3PC
was present in the growth medium the amount of growth
(320 Klett units) and the activity of the HMP pathway
(22.1%) remained at maximal levels, but a reduction in

r
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TABLE 11
Effect of the addition of different concentrations of 3-pyridylcarbinol to a thiamine-supplemented Vitamin-free Casitone
.
medium on growth and on glucose catabolism of S. aureus

% Glucosea
catabolized via
EM
HMP

concen tra ti on
µg/ml

Turbidity,b
Klett units

2

147

2.2

92.3

7.7

10

355

2.2

90.9

9.0

c;o

1~8

:L 0

9;>, 5

17.5

100

340

3.7

72.9

27.0

SQQ

325

4.7

74.9

25.1

1000

300

3.2

77.2

22.8

5000

320

1.5

77.8

22.1

TCA cycle
activity (%)

a , Glucose catabolic pathways participation and the TCA cycle
activity were estimated as described previously (see
methods).
b

Growth was determined by measuring the turbidity at 600 nm
after 17 hr.
The values are the average of two separate experiments.
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the TCA cycle activity from 4.7% to 1.5% was noted.
Since such separate effects on growth and on the HMP
pathway were observed depending on the concentration of
the analog used in the growth medium, studies were
conducted with various concentrations of niacin and the
results are shown in Table 12.

The results indicated

that 0.05 µg/ml of niacin in thiamine-supplemented
Vitamin-free Casitone produced almost maximal growth
(300 Klett units) without stimulating the utilization of
the HMP pathway for glucose oxidation.

Only 9-10% of the

glucose was oxidized via the HMP pathway. As the concentration ot niacin

wa~

increased from n.o5 to 0.25 µg/ml,

a gradual increase in the activity of the HMP pathway
was noted.

For example, maximum utilization of glucose

via the HMP pathway (21.6%) occurred at a concentration
of 0.25 µg/ml of niacin.

When the niacin concentration

,in the medium was increased to 1000 µg/ml, there was a
reduction in the growth rate as well as in the operation
of the HMP pathway.

For instance, decline in the turbidity

readings of 162 Klett units was observed, while the
relative activities of HMP and the TCA cycles were 13.4%
and 3.3%, respectively.

With the addition of 2000 µg/ml

there was complete inhibition of staphylococcal growth.
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TABLE 12
Effect of the addition of different concentrations of niacin to

a thiamine-supplemented Vitamin-free Casitone on growth and on
glucose catabolism of -s. aureus.
Nia=in added
µg/ml

Turbidity,b
Klett units

TCA cycle
activity (%)

% Glucosea
catabolized via
EM
HMP

o.oo

42

0.7

90.0

9.1

0.05

300

2.0

89.2

10.8

0.10

326

3.6

84.5

13.5

0.25

335

5.6

78.4

21.6

o. c;o

~J

.,

c;

7q 4.

::>O ..5

2.00

345

4.5

82.0

18.0

5.00

341

2.9

82.5

17.5

50.00

335

4.3

80.3

19.6

500.00

330

3.9

75.6

24.4

1000.00

162

3.3

86.6

13.4

2000.00

11

.

C\

a

Glucose catabolic pathway participation and TCA cycle activity
were estimated as described previously .(see Methods).

b

Growth was determined by measuring the turbidity at 600 nm
after 17 hr.
The values are the average of two separate experiments.
The niacin content of 2% Vitamin-free Casitone is
0. 0013 µg/ml.

L
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TABLE 13
Effect of the addition of different concentrations of pyridine3-sulfonic acid to a thiamine-supplemented Vitamin-free Casitone
medium on growth and on glucose catabplism of

concentration
µg/ml

Turbidity,b
Klett units

TCA cycle
activity (%)

s.

aureus

% Gfucosea
catabolized via
EM
HMP

250

201

1.7

89.3

10.7

500

272

1.2

92.0

8.0

1,000

380

1.4

92.7

7.3

2,000

405

3.0

85.8

14.2

5,000

345

3.5

80.6

19.4

10,000

430

3.5

68.4

31.6

20,000

425

3.2

70.0

30.0

a

Glucose catabolic pathway participation and TCA cycle
activity were estimated as described previously (see Methods).

b

Growth was determined by measuring the turbidity at 600 nm
after 17 hr.
The values are the average of two separate experiments.
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These results with niacin substantiated the present
study's previous observation in the case of 3PC where
low concentration of the vitamin was required for maximum
stimulation of growth and higher concentration was needed
for maximum operation of the glycolytic pathways.
Table 13 showed similar results; different concentrations of pyridine-3-sulfonic acid in Vitamin-free
Casitone were used with added thiamine.

Essentially

similar results were obtained as those reported with
niacin and 3-pyridylcarbinol (Tables 11 and 12), except
that there was a wider margin between the concentrations

---:i.--- _.::
F.

for m;,.i.:,d:r;.:.i.l gro•.r1th and for .Lna~d1:1al II.HP ~timul:i.tion.

Effect of niacin analogs on the glycolytic pathways.
(1)

Effect of 6-aminonicotinamide on the HMP

pathway of S. aureus.

The results with the 6-substituted

analog of niacin, 6-aminonicotinamide (6-AN), on the
growth and on the activity of the HMP pathway are shown
in Table 14.

When 100 µg/ml of this analog of niacin

was added to Vitamin-free Casitone, it completely inhibited
growth of

s.

aureus.

The turbidity of

<~5

Klett units

obtained after incubation for 24 to 48 hr was probably
due to traces of vitamins present in the growth medium.
There was no further increase in the growth when the
incubation was continued for as long as 72 hr ( results

l

TABI,E 14 <
~

Effect of 6-aminonicotinamide (6-AN) on th~ gl~cose catabolic pathways of S. aureus
Addition to
the 2% Vitaminfree Casitone
growth medium
None
None

Additions to
the resting cells
grown in column
1 medium
None

Incubation
time
hr
3

6-AN (100 µg/ml) +
thiamine (2 µg/ml)

TCA cycle
activity (%)

% Glucose
catabolized via
HMP
EM

0.4

8.3

91. 7

0.2

2.4

97.6

Niacin (2 µg/ml) +
thiamine (2 µg/ml)

6-AN (100 µg/ml) +
thiamine (2 µg/ml)

3

4.5

20.3

79.7

Niacin (2 µg/ml) +
thiamine (2 µg/ml)

6-AN (100 µg/ml) +
thiamine (2 µg/ml)

6

2.3

8.9

91. 9

Niacin (0.05 µg/ml)
+ thiamine (2 µg/ml)

None

2

2.4

9.0

91.0

Niacin (0.05 µg/ml)
+ thiamine (2 vg/ml)
+ 6-AN (100 µg/ml)

None

2

2.0

0.3

99.7

.

The cells were grown for 17 hr under various conditions as indicated in the 1st column.
After growth they were washed with and suspended in 0.05 M phosphate buffer with added
niacin, thiamine or 6-AN as shown in the 2nd =olumn. The flasks were placed on a rotary
shaker for the indicated time. These cells were then harvested and used in the usual
manner as described previously (see Methods).
,:

t
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not shown in Table 14).

Due to the lack of growth in medium

with added 6-AN, analyses of the glucose catabolic pathways
were not performed.
It was possible to study the effect of 6-AN on the
glycolytic pathways under resting cell conditions.

When

staphylococci that had previously grown in unsupplemented
Vitamin-free Casitone were washed and incubated in phosphate
buffer (0.05 M, pH 7.0)-glucose (0.9%) ·medium containing
6-AN(lOO µg/ml} and thiamine (2 µg/ml}

for 2-3 hr, there

was a reduc:;tion in ,the utilization of the HMP pathtTq.Y., .
from 8.3% to 2.4% (Table 14).
nf

rhE'! HMP parhway

re~uJting

Decrease in the activity
from thP. addition ot 6-aminu-

nicotinamide was also observed in niacin grown cells which
utilized HMP pathway maximally.

For instance, when

staphylococcal cells were first grown in supplemented
Vitamin-free Casitone and then incubated in buffered
-glucose with 6-AN and thiamine, the activity of the HMP
pathway was unaffected for the first 3 hr.

As the

incubation continued for 6 hr, a marked decrease in the
utilization of the HMP pathway (from 20.3% to 8.9%) was
noted.

This strongly indicates that 6-AN in some manner

inhibits the activity of the HMP pathway in

s.

aureus.

The results of the experiments (Table 14) also
indicated that when the staphylococcal cells were grown in

L
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Vitamin-free Casitone with added thiamine (2 µg/ml), niacin
{0.05 µg/ml) and 6-aminonicotinamide (100 µg/ml), there
was no inhibition of growth .. Turbidity of 300 Klett units
was reached within 17 hr of incubation {results not shown
in the table).

Analyses of the glucose catabolic pathways

of cells grown under these conditions demonstrated that the
oxidation of glucose via the HMP pathway was reduced to
0.3%, the lowest value ever recorded in the present study.
Such inhibition in the HMP pathway activity by 6-AN has
been previously shown in animal cells (22,40,41) .•
~

$2)

Effect of 6-hydroxynicotinic acid on the

·.1.CA \,.;.:ych. acL.i.v.i.t.y

or s.

au.reus.

lmalysis of

··~ ... .:..~;....::.

~ •.:.::c.:.~~

analogs {Table 9) has indicated that some of the niacin
analogs at high concentrations can completely replace
niacin for stimulation of both growth and HMP pathway
activity.

None of the compounds affected the TCA cycle

activity unless thiamine was present in the growth medium.
The results of glucose catabolic pathways with the addition
of 6-hydroxynicotinic acid {6HN) to the medium are shown
in Table 15.

The findings demonstrated that this 6-hydro-

xylated derivative of niacin, when added alone to the
growth medium, did not stimulate staphylococcal growth.
Similarly, the activities of the glycolytic pathways
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were not increased.

For instance, the growth within 17 hr

reached a turbidity of 75 Klett units (not shown in Table
15) and the amount of glucose catabolized via the HMP
pathway and the TCA cycle activity were 10.7% and 1.5%,
respectively.

When the staphylococcal cells were grown

in Vitamin-free Casitone with added 6-hydroxynicoti!l_ic
acid and thiamine, utilization of the HMP pathway remained
less than 10% while the relative activity of the TCA cycle
was increased by 3-fold (from 1.5 to 4.2%).

It should

be mentioned here that 6-HN or thiamine when added singly
had no stimulatory effect on the TCA cycle; nor did the
aadition of b-HN·and niaci..n·together to the growth medium
increase the TCA cycle activity (Table 15).
Observation of staphylococcal cells previously
cultivated in 2% Vitamin-free Casitone containing 1000 µg/ml
of 6-HN (Table 15) and then incubated with niacin under
resting conditions showed stimulation of both HMP pathway
and TCA cycle activities.

Under these conditions the

amount of glucose oxidized via the HMP pathway was 20.5%
and the relative activity of the TCA cycle was approximately
5.8%.

As shown previously (Table 1) that addition of

niacin alone did not stimulate the TCA cycle activity,
but increases only in the HMP pathway were noted.

This

r

TABLE 15
Alteration of the TCA cycle activity of

s.

aureus by 6-hydroxynicotinic acid (6-HN)

Addition to the
2% Vitamin-free
Casi tone growth
medium

Addition to the
resting cells
grown in column
1 medium

6-HN (1000 µg/ml)

None

1. 5

89.3

10.7

6-HN (1000 µg/ml)niacin (2 µg/ml)

None

0.9

76.4

23.6

6-HN (1000 µg/ml)

Niacin (2 µg/ml)

5.8

79.5

20.5

6-HN (1000 µg/ml)thiamine (2 µg/ml)

None

4.2

91. 7

8.3

Niacin (2 µg/ml)

6-HN (1000 µg/ml)

0.7

78.5

21.5

Niacin (2 µg/ml)thiamine (2 µg/ml)

None

4.5

81. 6

18.4

TCA cycle
.'lCtivity ( %)

% Glucose
catabolized via
EM
HMP (%)

Staphylococcal cells were grown for 17 hr in :he medium shown in the ·1st column,
washed with and suspended in O. 05 M phosphat ·~ buffer.
In some cases 6-HN or niaci·n
were added, as indicated in the 2nd column, :•.) the resting cells. The flasks were
incubated for 2 hr and the estimation of glu ::•Jse catabolic pathways was performed as "°
described previously (see Methods).
m

.t

..

r
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indicated that 6-HN was acting like thiamine in stimulating
the TCA cycle.

The data from Table 15 also showed no

increase in the TCA cycle if the cells were grown previously
in Vitamin-free Casitone with added niacin and then incubated with 6-hydroxynicotinic acid.
(3)

Effect of N-oxides of pyridine derivatives

on growth and on glucose catabolism.

Table 16 presents

the results of the studies of various pyridine derivatives
and their N-oxides on growth, HMP and on the TCA cycle
activities of

s.

aureus.

in general it was observed

that all N-oxides tested were better growth stimulators
than the corresponding parent compound.
N-oxide was an exception.

3-Hydroxypyridine-

For instance, addition of

pyridine or 2-picoline did not stimulate either the growth
or the metabolic activities of staphylococci.

However,

upon the addition of the corresponding N-oxides, pyridineN-oxide and 2-picoline-N-oxide, growth was stimulated as
was glucose utilization through the HMP pathway. The
concentration of N-oxides required to yield maximal cell
growth was generally lower than the concentration of the
parent compounds or of other pyridine derivatives.
G.

Uptake of 14c-niacin and niacin analogs.
(1)

S. aureus.

L

Uptake of niacin-14c by niacin-deficient
Incubation of staphylococcal cells previously
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TABLE 16

Effect of the addition of pyridine compounds and their N-oxides
to a thiamine-supplemented Vitamin-free Casitone on staphylo'
!;

r

coccal growth and glucose catabolism
compound
tested
(concn µg/ml)

Turbidity
(17 hr)
Klett units

TCA cycle
activity (%)

% Glucose
catabolized via
EM
HMP

340

4.5

81.5

18.5

Nicotinic acidN-oxide (100)

315

4.3

75.1

24.9

Nicotinamide (2)

342

4.2

80.9

19.9

Nicotinamide-Noxide (100)

360

7.4

84.9

15.l

3-Pyridylcarbinol
(100)

335

3.3

77.2

22.8

(:; 0 C)

J15

3 .. 2

82.1

Pyridine (1000)

61

0.8

93.0

7.0

330

2.2

84.3

17.7

65

0.6

94.6

5.4

340

3.0

80.2

19.8

360

4.4

81.5

18.5

3-Hydroxypyridine
(1000)

55

1.1

93.7

6.3

3-Hydroxypyridine
-N-oxide (1000)

96

1.5

89.5

10.5

Nicotinic acid
(2 µg)

3-PyridylcarbinolN·.. oxidc

Pyridine-N-oxide
(500)
2-Picoline (1000)
2-Picoline-Noxide (1000)
3-Picoline-N, oxide ( 5 0 0 )

% Glucose catabolized via the EM and the HMP pathways and the
relative activity of the TCA cycle were estimated as described
previously (see Methods).
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Figure 6.

90

120

(MIN)

Uptake of 14c-niacin by nonproliferating niacindeficient s. aureus.
Washed niacin-deficien~
cells equivalent to 3 mg (dry weight)/nl ~ere
incubated in buffered olucose containina
14c-niacin, 5 µg/ml (ll4508 C?m/ml of niacin).
The 14c content of the cells was determined at
the indicated time.

•

r

100

grown in unsupplemented Vitamin-free Casitone medium in
14
.
. t ure at 37 c con t aining
. .
.
. resulte d in
.
reac t ion
mix
C-niacin
an accumulation of the radioactive vitamin within the cells
(Fig. 6).

Niacin uptake was found to be linear with time for

about 30 to 40 min , reaching a maximum at 60 min.

Further

incubation, for periods up to 120 min , did not result in
an additional uptake of the vitamin.
(2)

pH Dependence of niacin transport.

The

results of studies on the uptake of niacin at different pH
values are presented in Fig. 7.

The vitamin uptake was

strongly influenced by the pH of the medium, the optimum pH

from S.S to 8.0, there was a reduction in the uptake of the
n

vitamin.

On the basis of these results it is concluded that

niacin enters the staphylococcal cells by a pH sensitive
mechanism, the optimum hydrogen concentration for niacin
,uptake being approximately S.S.
(3)

Temperature dependence of niacin transport.

The results of studies on niacin uptake by staphylococci at
different temperatures are shown in Fig. 8.

The niacin uptake

by resting cells of S. aureus was influenced by the temperature of reaction mixture.
occur at 50

c.

The maximum uptake was shown to

Cellular adsorption of niacin was found to

contribute little to the amount of niacin uptake, since brief

l
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12

S~S

6.5

7.0

7.5

8.0

pH
Figure 7.

Effect of pH on 14c-niacin transoort in
s. aureus. Conditions for the experiment
were same as described in Fig.6 except that
0.2 MK phosphate buffer was used in the pH
range from 5.5 to 8.0. The samples were
removed at the end of 60 min for the
estimation of radioactivity in the cells.
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(C)

Effect of temperature on 14c-niacin transport
in s. aureus. The conditions for the experiment
were same as described in Fig.6. The staphylococcal cells were incubated for 60 min at
indicated temperature, and the radioactivity
in the cells was determined as described
previously (see Methods).

65

103
exposure of cells to niacin at 0-4C resulted in insignificant
niacin uptake.

Since energy generation within the cells is

very low at this temperature, this also suggests that niacin
uptake is energy dependent.

(4)

Energy requirement.

Many microbial transport

systems are dependent upon, or are stimulated by, the presence
of an energy source (43).

In the experiments reported here,

the addition of glucose to the medium slightly stimulated the
uptake of niacin in vitamin-deficient staphylococcal cells
(Fig. 9).

Also, the addition of glucose to the incubation

significantly stimulated niacin uptake in the staphylococcal

(results are not included in the Fig. 9).

The mechanism

of stimulation of niacin uptake under this condition in the
present study is not well understood.

(5)

Effect of niacin concentrations.

The results

'Of experiments on the effect of niacin concentration on the
transport system in staphylococci are presented in Fig. 10.
The rate of niacin uptake increased with increasing niacin
concentrations in the medium and tended to become saturated
at lo-7 M.
(6)

Inhibition of niacin uptake by niacin analogs.

A measure of the specificity of the niacin transport system
was obtained by investigating the effect of several

l
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Figure 9.
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90

120

(MIN)

Effect of glucose on 14c-niacin transoort in
S. aureus. Washed niacin-deficient cells
equivalent to 3 mg (dry weight)/ml were
incubated in K phosphate buffer (pH 7.0)
containing 14 c-niacin, 5 µg/ml (114508 cpm/ml)
and/or 1% glucose.
Radioactivity in the cells
was determined at various intervals as
described previously (see Methods).
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of niacin by niacin-deficient S. aureus.
Experimental conditions were as described in
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structurally related compounds on 14c-niacin uptake (Table
17).

The presence of excess unlabeled niacin or of the

pyridine analogs containing a substituant in the 3 position,
3-pyridylcarbinol, quinolinic acid, 3-hydroxypyridine, 4chloronicotinic acid and 2-, 4-, and.5-hydroxynicotinic acid,
inhibited the accumulation of radioactive niacin.

However,

pyridine-N-oxide and isoniazid, neither of which are substituted at the 3-position of the pyridine ring, did not
inhibit the uptake process.
niacin uptake by

s.

Thus, the results indicated that

aureus is mediated by a transport system

having structural specificity for niacin and closely related
CUltllJOUlld::>.

(7)

Exchange between intracellular niacin and

extracellular niacin and its analogs.

Many compounds which

are accumulated by cells can be eluted from the intracellular
pool by exchange with extracellular compounds of the same or
similar structure (15).

This has been cited as evidence for

the existence of transport carrier systems in the cell membrane.

In the present experiments (Table 18) the exchange

between intracellular niacin and the extracellular niacin or
niacin analogs did not occur.

However, it should be pointed

out that after niacin entered the cells, it was quickly converted to nicotinamide coenzymes

NAD(P) and its inter-

mediates and thus did not remain in a free state (46, 33).

l
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TABLE 17
Inhibition of 14 c-niacin transport by niacin
analogs
% Inhibition

Unlabeled addition

Radioactivity in
cell counts/min

14c-niacin
uptake

12,850

o.o

15

100.0

3-Pyridylcarbinol

110

99.1

Quinolinic acid

135

98.9

Pyridine-N-oxide

11,325

o.o

Isoniazid

11,765

8.5

3-Hydroxypyridine

55

99.6

2-Hydroxyniacin

75

100.0

4-Hydroxyniacin

74

100.0

5-Hydroxyniacin

60

99.5

905

91.0

None
Niacin

4-Chloronicotinic acid

Staphylococcal suspensions containing 3 mg (dry weight) of cells
in 0.05 MK phosphate buffer, pH 7.0 and l ' glucose were exposed
simultaneously to 2 µg/ml of l~c-niacin (114508 cpm) and 2 mg of
unlabeled analog. After 30 min, the cell suspensions were
filtered, washed and then counted, as described previously (see
Methods).

L
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TABLE 18
exchange between intracellular 14 c of cells preloaded with 14cn_iacin and with unlabeled extracellular niacin or niacin analogs

Radioactivity (cpm/ml, cells)
Time
min

after addition of unlabeled
3-Pyridylcarbinol

Isoniazid

11,500

10,907

12,041

11,961

11,509

11,595

11,157

1.1,570

11,106

11,916

10,751

10,569

11,618

10,671

10,253

10,807

11,326

Buffer

Niacin

0

12,110

12,545

30

12,049

60
120

Quinolinic
acid

eel.ls preloaded with 14c-niacin as described previously (see
Methods}, were added at a concentration of 3 mg/ml (dry weight)
.,to flasks containing 0.05 M,potassium phosphate buffer pH 7.0,
1% glucose and either unlabeled niacin or niacin analogs at a
· final. concentration of 2 mg/ml.
Cells were incubated at 37 C,
samples removed at intervals and the' cellular radioactivity was
determined.
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(8)

Uutake of labeled quinolinic acid and isoniazid

by niacin-deficient S. aureus.

Staphylococcal cells took up

comparatively little isoniazid or quinolinic acid.

Fig. 11

and 12 show the uptake of two different concentrations of
isoniazid and quinolinic acid by staphylococcal cells under
resting cell conditions.

As the external concentration of

radioactive quinolinic acid was raised to 500 µg/ml, the rate
of uptake was found to be slightly increased during the 2 hr
incubation period.

The uptake, although low (l.0%), was

found to be maximal at a concentration of 500 µg/ml

(Fig. 12).

Similarly, small differences were observed in the uptake of

from 10 to 500 µg/ml in the medium (Fig. 11).

The uptake of

isoniazid was also time-dependent, as more 14c-isoniazid
entered the cells at the .end of a 6 hr compared to a 2 hr
period.

Analyses of the glucose catabolic pathways under

·identical conditions showed that there was an increase in the
utilization of the HMP pathway from 6.2 to 20.4% when the
concentration of isoniazid was increased from 10 to 500 µg/ml.
Similar results were obtained with quinolinic acid (results
not shown in Fig. 11 and 12).

Therefore, these results

indicated that although the uptake of the niacin analogs
isoniazid and quinolinic acid was low (2%), it was sufficient
to bring about the metabolic changes similar to those caused
by niacin.

110

16

12

0

!>UO µg/ml
10 µg/ml

4

I

2

3

INCUBATION TIME
Figure

L

11.

4

5

6

(HR)

Uotake of isoniazid-14c by nonproliferating
niacin-deficient S. aureus. Cells equivalent
to 3 mg (dry weight)/ml were incubated at
indicated time, in reaction mixture
containing either 10 or 500 µg/rnl of
isoniazid-14c (222635 cprn/ml, final concentration).
The uptake of the analog by the cells
was determined as described previously.
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Figure 12.

3

4

(HR)

Uotake of quinolinic acia-14c by nonproliferating niacin-deficient s. aureus.
Experimental conditions were as described
in Fig.11 except isoniazid was replaced
with quinolinic acia-14c.

IV.

DISCUSSION

In. the present study an attempt has been made to investi-

~
~

t

gate some of the £actors that might control the degree to
which the glucose catabolic pathways of staphylococci are

F'

t
~

'r

modified, as a result of the addition of either niacin and /or
thiamine to the growth medium.
The importance of an adequate supply of niacin and thiamine
in glycolysis (i.e., the conversion of glucose to pyruvate or
lactate without regard to metabolic pathways) has been studied
in staphylococci by Kligler et al.

(61).

According to these

investigators 2.5 times more glucose was used when both vitamins
were present in the growth medium than was used when niacin
.

dlone we:u:; µresent.

Results from the prPSPnt- studv

n;:n1p

~1

qo

indicated that there was an increase in the rate of glycolysis
when these vitamins were added to certain vitamin-deficient
growth media (Fig. 2), although addition of thiamine alone to
the medium did not result in stimulation of glucose utilization.
Thus, in the present study there were no differences in glucose
utilization by staphylococci grown in a medium containing
either niacin or niacin and thiamine.

The difference between

•

these results and those of Kligler et al (61) perhaps stems
from the use of resting cells in the present studies, previously
grown in the presence of vitamins, whereas Kligler et al.

(61)

analyzed glucose utilization from the medium by actively growing
cells.

l

112

113
In the present study it was found that, following the

I.

t~·

addition of niacin or niacin and thiamine to Vitamin-free

I

casitone, 18 to 22% of the glucose was oxidized via the HMP
pathway by the cells.

Surprisingly, the addition of thiamine

alone to the growth medium did not result in a stimulation of
the glucose oxidation through the HMP pathway (Table 1).

This

was an important finding since thiamine, in the form of
diphosphothiamine (DPT), is required as a coenzyme in this
pathway.

If the DPT coenzyme is missing or is present in

amounts that limit the expression of the full activity of the
enzyme, the effect would be the same as the absence of the
:-::1Z~'TI~,

pathway.

id.th

<J.

rcsul tant block in tl:c a.:-thrit;." c·f .the HMr

It has been shown that the addition of thiamine to

thiamine-deficient red blood cells stimulated transketolase
activity and HMP pathway, indicating that transketolase was
the rate-limiting step in the HMP pathway of red blood cells
(102).

A similar limiting role for transketolase in both yeast

and rat liver has also been demonstrated (6, 87), and the
addition of thiamine has induced transketolase in yeast (124).
Data from this dissertation have shown that when thiamine
was added to the medium, there was no stimulation of glucose
oxidation through the HMP pathway in staphylococci.

The lack of

the HMP stimulation by added thiamine may perhaps reflect that
there was already present an excess of the vitamin for transketolase activity.

l

On the basis of these findings alone, it is
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not possible to exclude the rate-limiting or regulatory role of
DPT-linked transketolase in the HMP pathway of

s.

aureus.

How-

ever, glucose oxidation via the HMP pathway increased markedly
following addition of niacin, without any thiamine and under the
conditions that precluded enzyme formation

(Table 5).

It may be

concluded that the activity of DPT-linked transketolase is not
limiting the activity of the HMP pathway under these c·onditions.
All living cells contain thiamine, if it is not supplied
exogenously then the cell must synthesize it.

Although, thiamine

was originally considered to be a vitamin required for the growth
of staphylococci (62), Idriss and Blumenthal (48) obtained
mooerar:e qrowth of' staphylococci. in n n, aC"!:l n-suppJ emented $yn-

thetic

medium~

free of thiamine ... The low rate of .. growth .and

increased HMP activity were consistent even after repeated
transfer of the cells in the absence of thiamine.

Based on these

findings, they concluded that there must be a limited endogenous
synthesis of thiamine in the cells.

Since the results of

radiorespirometric studies with the cells grown in niacin
supplemented growth medium lacking thiamine have shown that the
stimulation of the HMP cycle can occur in the absence of added
thiamine, then it is clear that the staphylococci can synthesize
enough thiamine to allow the HMP pathway to act at a maximal
rate.

Thus, thiamine is not limiting the activity of the HMP

pathway in staphylococci as it does in the red blood cells of
animals.

115
When staphylococci were grown in a vitamin-deficient medium
(2% Vitamin-free Casitone), with either added niacin or thiamine
alone, there was no stimulation of the TCA cycle activity.

In-

creased TCA cycle activity (10-fold) was only detected when both
niacin and thiamine were added to the growth medium.

The

mechanism of this stimulation, only after the addition of both
niacin and thiamine, is not presently understood, although the
coenzymes forms of both vitamins are required for the activity
of a number of enzymes in the TCA cycle.
Relatively large variations in the degree of utilization of
the glycolytic pathways of staphylococci were observed when the
cell8 were g1.own i11 different grow'Lh media.

~'or

example, \Yhen

staphylococci were grown in Vitamin-free Casitone-containing
both vitamins, the amount of glucose catabolized via the HMP
pathway was 18% as compared to a value of 35% when the cells were
grown in synthetic medium supplemented with niacin and thiamine
(Table 1).

Similarly, it had been shown that the addition of

niacin and thiamine to Trypticase growth medium (which contains
glucose} yielded cells that oxidized 46% of the glucose via the
HMP pathway (81}.

Thus, these results demonstrate that the

relative degree of utilization of the HMP pathway in S. aureus
is significantly affected by the nature of the growth medium.

At

present, the reasons for the absolute differences in the degree
of utilization of the glycolytic pathways of staphylococci grown
in different growth media are not fully understood.

However, it

r

..

•
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iS clear in all instances studied that the addition of niacin or
niacin and thiamine to the growth medium (Vitamin-free Casitone,
synthetic medium or Trypticase broth) results in the growth of
cells which have the property of oxidizing increased percentages
of glucose via the HMP pathway.

To minimize complications·

resulting from the use of complex media, Vitamin-free Casitone
medium was used for most of the experimental work.
Until now we have considered the percentage of glucose
molecules metabolized by the EM and by the HMP pathways.

It is

possible that one may receive a distorted view if the actual
amounts of glucose traversing these pathways are not considered •
l''('lT

Pxamp.l e, in

mutant~

of

~monella

'FYPh!,!11U£!·E.12 and, ot

Escherichia coli, deficient in phosphoglucose isomerase, the EM
pathway was found not to operate efficiently because of this
enzyme deficiency and the rate of both growth and glucose
utilization was only about 20% of that noted in the parent
strain.

Although, the mutants used less total glucose, the rate

of utilization of glucose via the HMP pathway (3 µmoles/mg/hr)
was approximately the same as that observed in the parent strains
(29, 30).

Consequently, the percentage of glucose oxidized by

the HMP pathway increased, but only because the amount going
through the EM pathway decreased.

An analysis of the results

with staphylococci indicated that an analogous situation occurred
When the percentage of glucose being oxidized via the HMP pathway

L
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increased after the addition of niacin.

The difference was that

the amount of glucose being oxidized via the EM pathway remained
relatively constant (or increased slightly) while the amount
oxidized via the HMP pathway increased significantly.
The usual percentage of glucose catabolized via the HMP
pathway in niacin-deficient cells is 6%, and since there are
only 2 pathways, by difference, the amount catabolized via the
EM pathway is 94%.

About 33% more glucose was used by niacin-

rich cells than was used by cells grown in the absence of the
added vitamins, and one might ordinarily expect this extra
glucose to be catabolized by the two glycolytic pathways in the

experiments (Table 1) indicated that in niacin-rich staphylococci,
the amount of glucose oxidized via the HMP pathway increased to
about 20% while, by difference, the amount oxidized via the EM
was reduced to 80%.
In niacin-rich cells the actual amounts of glucose traversing
the EM pathway each hour was 9.6 µmoles/hr

(12 µmoles glucose/hr

x 80% glucose oxidized via EM= 9.6) and by difference, since a
total of 12 µmoles/hr were used, the amount of glucose oxidized
'via the HMP must be 2.4 µmoles/hr.

In a similar manner, vitamin-

deficient cells used 8.5 µmoles/hr via the EM pathway (9 µmoles/
hr~

94% glucose oxidized via EM= 8.5) and by difference, since

a total of 9 µmoles of glucose/hr were used, the amount of glucose

l

.r-· . •

.

':ti
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ox~<?:1- Zt'.1i ·1ia the HMP pathway was 0. 5 µmole/hr.

Thus the

~nclusi.•11 1 of niacin in the growth medium resulted in a

relativ.:J-; slight increase in the amount of glucose utilized
v~a the r:.i1 pathway

(from 8. 5 to 9. 6 µmoles/hr), while there was

a 5-folii .i.ncrease (from O. 5 to 2. 4 µmoles/hr) in the glucose
oxidati•111 through the HMP pathway.

Although the addition of

?iacin ILsulted in a decreased percentage of glucose being
metabol i l<:d via the EM pathway (from 94% to 80%), the actual
a.m~unt

11r glucose used via this pathway increased slightly.

!h~ !n~f~9sed rate of glycolysis in niacin-rich cells was

P!"!!Il?!"il/ due to the additional passage of about 2 µmoles of

~!~~()~o ~!f~ilized via the EM pathway remained essentially the

same in ~bth niacin-rich and niacin-deficient staphylococcal
c::ells.
in ent 2

'1'1-zis _is the reverse of the findings by Fraenkel (29)
1

I~ bacteria where the bacterial mutants, with deficien-

~~es or "Hl EM enzyme, had significantly reduced amounts of

' ·
· t h e EM pat h way b ut re 1 ative
· 1y
'·"'tng
oxi·a·ize d via

g lucos~

~<::m~t9n t

'lmounts via the HMP pathway.

•

Wlku one disintegrates staphylococci and assays the levels
of the i 11•lividual glycolytic enzymes in vitro under conditions
that art: • •Ptimal for substrate and coenzyme concentrations, such
assays •1" not necessarily yield information about the activity
of thes,,
reveal

0

t J,c.

nzymes within the cells.

These analyses, however,

potentialities (i.e., the maximum activity of that

l
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enzyme under optimal conditions) of the individual enzymes.
Enzymes which play a requlatory role in determining the proportion of glucose that is metabolized via one of the two
pathways will also suffer the same limitations during in vitro
assays.

Consequently, an attempt was made throughout the

present study to use both in vivo and in vitro techniques to
estimate the activity of a metabolic pathway.
The pattern of 14co

2

production from 14c-labelled glucose

by staphylococci which had been grown in media supplemented with
both vitamins, strongly indicated the stimulation of both the
HMP pathway and the TCA cycle.

Measurements of the enzyme

glycolytic pathways were due to the synthesis of _increased
amounts of enzymes.

Thus, there were striking and consistent

increases in the activity of G6PD and 6PGD when the HMP pathway
operated maximally and similar increases in ICD were noted when·
the TCA cycle activity was stimulated (Table 1 and 2).

Under

various growth conditions, the activities of the two HMP enzym'?"
(G6PD and 6PGD) were shown to be closely related to the level o=
staphylococcal glucose catabolism via the HMP pathway, as indicated by the ability to convert C1 of glucose to co 2 •

A similc::_-

relationship was found between ICD levels and the TCA cycle
activity, as indicated by the release of C02 from C6 of glucose.
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Th~

markedly increased levels of G6PO (ca. from 45 to 160

units} that were found in staphylococci following the additon
of the vitamins to the growth medium were accompanied by a
tripling in the percentage of glucose oxidized via the HMP
pathway in S. aureus (Table 2 and 3).

Such increased utili-

zation of the HMP pathway and accompanying increased content of
HMP enzymes have also been observed in yeast and mammalian .
systems (80, 87, 109).
Experiments with cell-free extracts, in which the individual enzyme may be added to those already present in the extract,
have also yielded some useful information about the role of

For example, the addition of phosphohexose isomerase and glucose6-phosphate dehydrogenase (G6PO) to a hemolysate·of normal red
blood cells resulted in an increase in the amounts of glucose
metabolized via both the EM and the HMP pathways.

When hemo-

lysates were prepared from G6PD deficient blood cells, added
phosphohexose isomerase was without any apparent effect, indicating that the enzyme was already present in excess, whereas
•
the addition of G6PD caused a 4-fold increase (from 13.1 to
45.8%} in the amount of glucose oxidized by the HMP pathway,
thus confirming its rate-limiting role. It should be noted that
these experiments with cell-free extracts were carried out on the
Presence of optimal concentrations of NADP required for the HMP

l
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pathway stimulation.

Since the present studies with staphy-

1ococci resulted in the conclusion that the enzymes were not
~

t
[-'

r

1imiting the rate of glucose oxidation via the HMP pathway,
similar experiments were not performed.

~

f·

The results of the present experiments indicated that when
staphylococci were grown in supplemented Vitamin-free Casitone,
increased G6PD activity was always paralleled by increased IL.'1P
pathway activity (Table 2 and 3).

From this observation it

appeared that the level of G6PD in some manner limited the
activity of the HMP pathway in staphylococci.
The first indication that the enzyme levels were probably

of the

gluc~se

I

was metabolized via the HMP pathway when

s.

aureus was grown in synthetic medium containing excess amounts
of niacin and thiamine, compared to only 18% when these vitamins were added to Vitamin-free Casitone (Table 1).

In spite of

the increased level of activity of the HMP pathway in the intact
cells, the activities of G6PD and 6PGD, two of the key enzymes
in the HMP pathway, from extracts derived from the synthetic
medium, were only 2/3 as much as those derived from cells grown

l

in Vitamin-free Casitone with added niacin and thiamine (Table 2).

Therefore , it appeared that increased amounts of the glycolytic

r

!
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enzymes were not necessary for more active operation of the HMP
pathway in staphylococci.

A similar situation existed for the

TCA cycle.
In order to get more direct information on the role of
enzymes in the regulation of the H.MP pathway, we undertook experiments with resting cells.

Under resting cell

co~ditions

protein synthesis in the cells is minimized due to the absence
of a nitrogen source in the incubation medium.

Although some

turnover of protein is expected in the cells, there can be no
net increase in protein synthesis.

Thus under resting cell

conditions the effect of vitamins on metabolic pathways can be
examined with minimal changes in enzyme levels.
Radiorespirometric studies showed that the incubation of
vitamin-deficient staphylococci, possessing a relatively low
percentage of glucose oxidation via the HMP pathway, with the
vitamins in the buffered-glucose medium converted them to
staphylococci with glycolytic characteristics similar to those
of cells that had been grown in the presence of the vitamins
(Table 4).

The amount of glucose catabolized via the HMP

pathway was approximately 19%, whether the vitamin supplementation had been made under growing or resting cell conditions.
The stimulatory effects of the vitamins on the activity of the
TCA cycle were similarly observed.

Enzyme analyses indicated

that the levels of the two key HMP enzymes were only 30% of
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those observed under growing conditionsr even in spite of a
greater utilization of glucose via the HMP pathway (Table 3
and 5).

This clearly indicated that the HMP enzymes G6PD and

6PGD were not limiting the activity of the HMP pathway in vivo.
To further ensure that protein synthesis was not proceeding
in the resting cells as a result of the utilization of amino
acids from either an endogenous amino acid pool, and/or from a
low level of protein turnover, one of the following three
antibiotics, inhibitors of protein synthesis, chloramphenicol,
actinomycin D or puromycin, were added along with the vitamins
at concentrations ranging from 6 to 100 µg/ml..

Growth of the

chloramphenicol and actinomycin D at concentrations of 6 and
0.6 µg/ml, respectively (120).
were

essentia~ly

The findings of the experiments

the same as those wi.th the resting cells

suspensions, namely, that none of the antibiotics were able to
prevent the stimulation of the HMP pathway or the rise in the
levels of NAD and NADP, following the addition of niacin to the
vitamin-deficient staphylococci.

Furthermore, the enzyme levels
•
in the HMP pathway did not increase in the cells with the in-

creased HMP activity .(Table 6).

Surprisingly, it was found that

actinomycin D actually stimulated utilization of the HMP pathway
and also increased NAD level.

The mechanism of this stimulation

by actinomycin D is not presently understood and was not
investigated further.

r

1.24

Based on the results just discussed it was concluded that
the stimulation of the HMP pathway caused by the addition of
niacin was not related in any way with the synthesis of enzymes.
Since the levels of the glycolytic enzymes within the
cells are not the rate-limiting factors in staphylococcal
carbohydrate metabolism and do not play a regulatory role in
the HMP pathway of

s.

aureus, any changes in enzyme levels

within cells resulting from the addition of the vitamins to
the growth medium are probably secondary to the changes in
nicotinamide coenzyme levels.

This will be discussed further

in this section •

.Ln contra.st to tne present resuJ.ts with staphylococci, the
levels of enzymes have been claimed to play a significant role
in determining the degree to which the EM and HMP glycolytic
pathways are utilized.in yeast (87).

The findings with the

yeast were based on the fiact that when yeast were grown with
nitrate as the nitrogen source, instead of with amino acids as
the nitrogen source, there was an increase in the levels of the
enzymes, G6PD and transketolase, along with increased 14co 2
production from glucose-1-14c, indicating more active operation
of the HMP pathway.

It was also noted that the addition of the

antibiotic, cycloheximide, to the growth medium prevented both
new enzyme synthesis and increased activity of the HMP pathway.
From these findings, it was concluded that new enzyme synthesis
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was necessary for increased operation of the HMP pathway and
that there was a strong correlation between the level of G6PD
and the degree of operation Qf the HMP pathway in yeast.
In the present study, it was also found that the levels
of G6PD and 6PGD paralleled the degree of utilization of the
HMP pathway in staphylococci under growing conditions (Table 3).
However, in the present study suitable experimental conditions
were found which demonstrated that the increased utilization of
the glucose through the HMP pathway, as a result of the addition
of vitamins, occurred without the synthesis of these enzymes
(Table 3).

On the basis of these findings, it is concluded that

the HMP pathway in staphylococci.

This may just represent

examples of different controlling factors in different microbes.
The measurement of enzyme. level~. in the cells that had been
incubated with chloromphenicol eliminated the possibility of any
enzyme formation in the present study through activation or
assembly of polypeptide precursors, such as is thought to occur
in the formation of enterotoxin B by S. aureus, even in the
presence of chloramphenicol (74).
Induction of G6PD synthesis by coenzymes, vitamins and
metabolites has been observed in animal and microbial cells (3,
10~,

123, 124).

For instance, thiamine in the form of

diphosphothiamine induced the synthesis of pyruvate decarboxylase

r
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in yeast, with resultant increase in glycolysis (123).

This

finding was based on the observation that pyruvate decarboxylase
activity increased by 50% during the incubation of yeast cells
with glucose and thiamine and by 300% when the cells were incubated with glucose, thiamine and a nitrogen source.

Simi-

larly, an increase in the pyruvate decarboxylase activity was
prevented by the inclusion of proflavine, p-fluorophenylalanine
or 5-fluorouracil in the incubation medium.

These results

indicated that the higher activity of pyruvate decarboxylase
after incubation with thiamine was due to the stimulation of
de

~

synthesis of the enzyme and not an activation of pre-
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thiamine also induced transketolase (124).
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There ·are al.so other

examples which support the finding_that cofactors of an enzyme,
in addition to

re~ulating-the

activity of the existing enzyme,

may influence the amount of the protein moiety of the same
enzyme that is found in vivo (37).

However, ins. aureus,

there was no increase in the levels of the glycolytic enzymes,
when the vitamins were added under resting cell conditions,
although the glycolytic pathways were maximally stimulated
(Table 4).

The additional use of antibiotics in the experiments

(Table 6) eliminated any possibility of new protein synthesis
occurring in the cells.

Based on these results it can be con-

eluded that there was no induction of glycolytic enzymes in
~ ~·

aureus by the added vitamins.
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Since the enzyme levels were not responsible for regulating the relative amounts of glucose being metabolized by the
EM and the HMP pathways in st.aphylococci, we next considered
the possible regulatory role of NAD and NADP levels.

NADP

has been shown to be an important regulator of the HMP cycle
in various microbial and mammalian systems (24).

In numerous

in vitro experiments it has been shown that the addition of
either electron acceptors which would reoxidize NADPH to NADP
or of enzyme systems capable of converting NADPH to NADP,
resulted in increased glucose oxidation via the HMP pathway
(121).

Thus the NADP concentration and/or the rate of NADPH

glucose degradation via the HMP pathway.
In cooperative studies with R. Hoo (46) in this laboratory,
it was observed that the levels of nicotinamide coenzymes in
staphylococci always increased in parallel ·with increased
levels of glucose oxidation via the HMP pathway following the
addition of niacin either under growing or resting cell conditions (Table 6).

For instance, it was demonstrated in staphylo-

coccal cells that when niacin was added to the growth medium,
there was a 15-fold increase in NAD and a 2-fold increase in
NADP levels at the same time there was a 3- to 4-fold increase
in ·glucose oxidation via the HMP pathway.

This suggested that

either the levels of NAD and/or NADP played a regulatory role
for the amount of glucose oxidation via the HHP pathway.

L
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The regulatory role of NADP in the activity of the HMP
pathway in various microorganisms has been well established (14).
However, NAD has not been previously proposed to be involved in
controlling the overall activity of the HMP pathway.

It is

difficult to imagine how NAD would control some of the enzymatic
reactions of the HMP pathway since NAD does not serve as a
coenzyme in this pathway, with the exception of few microbes
(13, 125).

In staphylococci, the enzymes G6PD, 6PGD and ICD

all had a specific coenzyme requirement for NADP in the three
assay systems.

It should be noted that only crude cell-free

extracts served as enzyme sources in the present studies.
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of NADP (0.1 mM) did not influence the rate of enzymatic
reactions.

These results suggested that the NAD levels did not

stimulate the activity of HMP enzymes in vitro, and therefore,
it appears that the role of NAD in regulating the HMP pathway in
staphylococci, is probably due to some mechanism other than the
direct stimulation of G6PD and 6PGD activities.
Nozawa and Mizuno (86) observed a reduction in the intra•

cellular NAD level in niacin-requiring E. coli during the course
of "starvation''.

The NAD content decreased to one

tenth of

normal level after two hr of incubation of washed cells in
buffered glucose.

Therefore, similar experiments were designed

to determine whether such a variation in NAD could be observed
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in staphylococci during starvation and, if so, to correlate the
NAD and NADP levels with the degree of utilization of the two
glycolytic pathways.
Incubation of washed resting staphylococcal cell suspensions that had previously been cultivated in Vitamin-free
Casitone containing niacin (0.5 µg/ml), resulted in a reduction
in the HMP pathway from 18% to 10%, while the intracellular NAD
level decreased from 2.2 to 1.5 µmoles/g

(Fig. 3).

During this

incubation for 6 hr in the vitamin-free buffered glucose
solution, while the NAD level decreased, the NADP level remained
constant or increased very slightly.
niacin

{~UU

µg/m~J

However, the addition of

to the incubation medium at the end ot the b

hr period led to a simultaneous increase in the HMP pathway
utilization (to 19%) and the NAD content (to 4 µmoles/g) without
a corresponding increase in the NADP level (Fig. 3).

Replacing

niacin with pyocyanin (an electron acceptor) in the incubation
medium also resulted in an increase in the utilization of the
HMP pathway (from 10 to 22%) without increasing the coenzyme
levels.

These results suggested that NAD and pyocyanin probably

acted in the same manner while stimulating the activity of the
HMP pathway, by reoxidizing NADPH to NADP.

In the case of

pyocyanin, the action was directly on the NADPH, while the NAD
probably acted via the transhydrogenase system with NAD being
reduced to NADH during the concomitant oxidation of NADPH to
NADP.
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On the basis of these results it appeared that a certain
intracellular NAD level was necessary, in addition to the level
of NADP, in order to allow this expanded operation of the HMP
pathway in S. aureus.

Under the conditions studied here, with

a relatively constant NADP level of about 0.4 µmoles/g, as the
NAD concentration was reduced to a value below 2.2 µmoles/g,
the HMP pathway ceased to operate maximally.

The importance of

the NAD level in allowing the augmentation of glucose oxidation
via the HMP pathway was further substantiated by the finding
that when the NAD level was restored to 2 µmoles/g following
the addition of niacin at the end of the 6 hr incubation period

level.

These results suggested that the NAD leve-1 in some

manner played a regulatory role in the degree of operation of
the HMP pathway in staphylococci.
In highly oxidative organisms such as Pseudomanas saccharophila and Pseudomonas fluorescens, which predominantly
utilize the HMP and/or ED pathways, with little or no EM pathway, intracellular levels of NADP are relatively low.

For

example, the level of NADP in these two organisms 0.8 µmoles/g
and 0.04 µmoles/g, respectively (71).

In such organims the

potential rate-limiting effect of NADP on the activity of the
HMP and ED pathways has been overcome by the presence of active
NADPH oxidase and of transhydrogenase
rapid reoxidation of NADPH to NADP.

(24) resulting in a very

r
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In S. aureus the level of NADP was found to be in the
range of 0.6 µmoles/g when the HMP pathway was being utilized
maximally (45).

This level of NADP was similar to those found

in other facultatively aerobic and anaerobic microbes, such as
E. coli, B. subtilis and P. saccharophila (71).

In the present

study with S. aureus no definite correlation was found between
the transhydrogenase and NADPH oxidase activities and the degree
of utilization of the HMP pathway.
enzymes (Table 5) in

s.

The low activities of these

aureus could be explained on the basis

that the EM pathway still served as a major glucose catabolic
route (78%), even when the HMP pathway operated maximally (22%).
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oxidase, found in S. aureus, were probably sufficient to generate NADP for the H.MP pathway activity.

Such is the case in

B. subtilis and also in E. coli, which do not use the HMP pathway as the major route for glucose catabolism and which also
contain relatively low amounts of NADPH oxidase and transhydrogenase (24).

Furthermore the finding that the expanded acti-

vity of the HWF pathway in S.aureus required a NAD level of
greater than ca. 2 µmoles/g can best be interpreted to mean
that the transhydrogenase system is involved in NADP regeneration even in the facultative anaerobes such as S. aureus.

To

our-knowledge this is the first instance that the exoerimental
evidence supports this concept in any microbe other than the
strict aerobes such as pseudomonas.

r
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One of the major conclusions drawn from the experiments
just discussed was that the addition of niacin to the growth
medium stimulated the glucose utilization via the HMP pathway
by increasing the cellular levels of both the glycolytic enzymes
and the nicotinamide coenzymes, NAD(P).
use of resting cell

conditions~

However, through the

it was demonstrated that the

increased levels of enzymes were secondary effects and that
certain intracellular NAD and/or NADP levels were required for
the regulation of the HMP pathway in

~-

aureus.

The results of the present experiments have indicated thus
far that either the level of NAD and/or NADP may be involved in

.
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In order to

obtain staphylococcal cells in which there were further variations in the coenzyme levels, some niacin analogs were employed
in the present studies.

The niacin analogs isoniazid and 6-

aminonicotinamide have been known to reduce the intracellular
levels of nicotinamide coenzymes in both microbial and
mammalian systems (40, 41, 122).

Surprisingly, it was found
•

in the present studies that many of the niacin analogs were able
to completely replace the niacin requirement for staphylococcal
growth.
pursued.

Therefore, further studies with the analogs were
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Previous investigations with niacin analogs had indicated
that quinolinic acid, picolinic acid, isonicotinic acid,
ce~tain

nicotinyldiethylamide, and

other pyridine derivatives,

when added to the growth medium at concentrations of l0- 4M
(ca. 0.15 µg/ml), could not replace niacin as a growth factor for
staphylococci (62, 68, 69).

These failures to replace niacin and

to permit growth were not due to the toxicity of the compounds
since staphylococcal growth resumed following the addition of
nicotinamide to media containing the various compounds.

The

results of the present studies, which are summarized in Table 10,
confirmed these findings when the analogs were used at concenTT-.-·---- -
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the analogs in the growth medium (containing thiamine) was
increased from a level of 10 to a level of 100 or 1000 µg/ml
all of the analogs in Group I

(Table 10) stimulated staphylo-

coccal growth to approximately the same

degr~e

as niacin.

For

example, 3-AP or PSA added to a thiamine-supplemented 2% Vitaminfree Casitone growth medium at a concentration of 10 µg/ml
produced a turbidity of 70 Klett units, approximately the same
as that of the control.

However, when the concentration

of the

analogs was increased to 1000 µg/ml in the medium, the turbidity
increased to 343 Klett units.

This compares to a value of 340

Klett units when niacin was used at a concentration of 2 µg/ml.
Similar results were obtained with most of the other analogs from

r
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Group I

(Table 10).

In the absence of added

thia~ine,

however,

the growth stimulation was either absent or minimal (Fig. 4 and
Table 7), even when high conqentrations of niacin analogs were
used.
When analogs from Group II

(Table 10) were added to a

thiamine supplemented Vitamin-free Casitone medium even at concentrations of 1000 µg/ml, they were unable to stimulate growth
maximally.

For example, when either

6-chloronicotin~uide

or

picolinic acid was added to the growth medium at a concentration of 1000 µg/ml turbidity readings of only.170-180 Klett
units were obtained.
--
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This amount of growth was only approxi...._,__
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It is conceivable that

maximum growth (ca. 340 Klett units) might occur with Grou-::> II
analogs if even still higher
ployed.

concentratio~

of analogs were em-

This suggestion is based on the results of

ex~eri~e~ts

with various concentrations of Group I analogs on the grohth of
staphylococci.

For instance, data from Table 13

at a concentration of PSA of 250 µg/ml only half
occurred (201 Klett units) compared to the

in~icats~
maximu.~

maximtL~

t~at

grohth

growth of

400 Klett units that resulted following the addition of 2COO
µg/ml or more of PSA.
Analogs from Group III failed to support staphylococcal
growth in 2i ther Vi ta"1in-free Casi tone or in synthetic r::ec.2. ;.;..-:-..

135
while the analogs in Group IV were inhibitory to even the low
levels of growth able to occur in the basal media.

Concen-

trations of Group III analogs_ as high as 1000 to 5000 µg/ml
were unable to stimulate the growth above the control level.
The complete inhibition of staphylococcal growth by the Group
IV analogs, 6-AN, 5-FlN, pyrizinamide and 3-hydroxypicolinic
acid, is in agreement with the findings of other workers

(47,

104, 114).

The use of completely synthetic media for the growth
studies showed that many niacin analogs were successfully
utilized and converted into nicotinamide coenzymes by staphyloP~-
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of any of the 25 Group I analogs to a thiamine supplemented
synthetic medium completely replaced the niacin requirement for
staphylococcal growth (Table 7).

With the addition of 3-AP or

NNO to synthetic media with added thiamine, turbidity readings
of 205 and 343 Klett units, respectively, were obtained.

These

values are comparable to that obtained with added niacin (270
Klett units).

Analogs from Group III and IV also failed to

stimulate staphylococcal growth in the synthetic medium, confirming the results in the Vitamin-free Casitone medium.
To insure that the niacin analogs were effective in more
than the Towler strain of

s.

aureus, 10 additional strains of

S. aureus, 3 strains of S. eoidermidis and 3 niacin-requiring
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Gram

~egative

bacteria were tested for their ability to utilize

niacin analogs in place of niacin.

Our results

(Table 8) showed

that 3-AP (1000 µg/ml) or NDA (100 µg/ml) when added to thiamine
supplemented Vitamin-free Casitone, stimulated the growth of all
strains of S. aureus and S. eoidermidis.

Although the growth

response varied somewhat from strain to strain, the growth stimulation by 3-AP and NDA was generally similar to that of niacin.
Similarly, Proteus vulgaris, Proteus morgani and Shigella
flexneri also utilized 3-AP and NDA as a growth factor in place
of niacin.

When Shigella flexneri was grown in Vitamin-free

Casitone containing added 3-AP and thiamine, _turbidity measure-

units obtained from the addition of niacin and thiamine.
Successful utilization of 3-AP, PSA and NNO as a growth factor
by dysentry bacilli and by other Gram negative bacteria has
been previously observed (82, 92).

Thus the results of these

studies strongly indicate that the utilization of niacin analogs
is a general feature among the niacin requiring microbes.
The discrepancies between the negative results of previous
investigators

•
(25, 63, 68, 69) and the results of the present

studies are probably due to the concentrations of analogs and
the type of growth media employed in their studies.

Previous

workers had failed to observe any stimulatory effect on the
growth of S. aur9us due to the fact that very low concentrations
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(10-5 to 10- 4 M) of analogs had ;pen used in their studies.
These concentrations were simil0r to the concentration of niacin
usually required for

staphylocos~al

growth.

The results re-

ported in this dissertation (FiJ. 4 and 5) indicated that the
concentrations of the analogs rc:: iuired were at least 100- to
0

1000-fold higher than the 0.1

~J/ml

support the maximal growth of

s.

of niacin necessary to

dureus.

As will be discussed

later, the need for such high c0ncentrations is probably due to
the lack of an active transport :;ystem for the analogs in
staphylococci.
The data from the present study (Fig. 4 and 5) indicated
~
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were tolerated by staphylococci ·.·: i. thout any adverse effects on
th~i~

ability to grow, eventually a concentration was reached

which caused growth inhibition.

:or example, addition of

niacin, at concentration rangins

~=om

lated maximal staphylococcal

gro~~~

0.1 to 500 µg/ml stimu-

and at least 0.25 µg/ml

was needed for maximal stimula ti,':: of the HMP pathway.
at a concentration of 1000 µg/ml

~22re

However,

was a 50% reduction in

growth, while glucose oxidation :>.:-ough the HMP pathway decreased from 21.6% to 13.4%

(Tabl~

to the medium at a concentration
inhibition of staphylococcal

12).

~=

gro~~~-

large concentration of niacin or

~:3

When niacin was added

2000 µg/ml, there was complete
The inhibitory effect of
analogs was probably due to
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the nutritional imbalance in the medium and is in agreement with
the findings of other workers that concentration of niacin above
1 mg/ml inhibited growth of niacin-requiring bacteria (65).
Fig. 5 shows that there was no lag in the growth of
staphylococci in the presence of the niacin analogs.

This in-

dicated that the stimulatory effects of niacin analogs on
staphylococcal growth were not due to the selection of mutants
capable of using the analogs.

If such

a

selection of mutants

were involved, then one would have expected to find either
longer or shorter lag periods during growth on various occasions.
Such growth variations in present study were not observed.

while investigating the effect of pyrithiamine, a thiamine
analog, on

~-

aureus, had shown that the ability to use pyri-

thiamine involved the selection of mutants.

Furthermore, these

mutants possessed properties indicating that major biochemical
changes were present in the mutant cells.

Present data has

conclusively demonstrated that the addition of either niacin
or niacin analogs produced similar biochemical changes in the
staphylococcal cells, even under non-growing conditions (Table
9 and 10).

Consequently, the involvement of mutants can be

eliminated from consideration.
- Studies with specifically-labelled 14 c-glucose have demonstrated that the niacin analogs successfully replaced niacin in

r
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stimulating the utilization of the HMP pathway in staphylococci
(Table 9).
analogs

The results indicated that when niacin or its

(Group I) were added to the growth medium, the increased

amount of glucose utilized via the HMP pathway (18-24%) and the
increased relative activity of the TCA cycle (4-5%), were
similar in both cases.

The mechanism of glucose oxidation via

the HMP pathway is discussed later in this section.
The interesting finding that lower concentrations of niacin
or niacin analogs were required for maximal growth than the concentrations of these substances that were required for maximal
stimulation of glucose oxidation by the HMP pathway, was first
'l'h11c::_

rni:>

rinn1r1nn

of 10 µg/ml of 3-pyridylcarbinol to the growth medium produced
maximal growth stimulation (355 Klett units) although the cells
obtained from this medium only oxidized about 10% of added
glucose via the ID1P pathway.

A concentration of 100 µg/ml of

this analog was required for both maximal growth and maximal
glucose oxidation through the HMP pathway (27%).

Following this

discovery, the effect of lower concentrations of niacin were
examined for their effects on both growth and the HMP pathway
participation.

It was found that addition of 0.05 µg/ml of

niacin to the medium resulted in maximal growth stimulation
while maximal stimulation of glucose utilization via the HMP
pathway required a concentration of at leasE 0.25 µg/ml
12).

(Table

The absolute difference between the concentrations of
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niacin allowing maximal growth stimulation and maximal stimulation of the HMP pathway was only o.2 µg/ml and had not been
observed prior to the studies with the analogs.

With the

analogs such as PSA or 3-pyridylcarbinol this difference was
much more readily apparent.

For example, with 3-pyridyl-

carbinol the difference was 90 µg/ml and for PSA it was 1750
µg/ml.

These findings clearly proved that the maximal opera-

tion of the HMP pathway was not a necessary requirement for
the maximal growth of staphylococci.
The minimal contribution of glucose oxidation through the
HMP pathway under conditions that will still allow staphylococci

.-v
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though the usual percentage of glucose oxidized by staphylococci
via the HMP pathway is 7 to 8% in Vitamin-free Casitone growth
medium not supplemented with niacin, this value was reduced to
0.3% when 6-A.t."'\J was included along with niacin in the growth
medium (Table 14).

Streightoff (114) had previously shown

that the growth inhibitory effect of 6-AN was nullified by the
inclusion of niacin in the growth medium.

However, he had

not studied any biochemical properties of these cells.

In the

present study when 100 µg/ml of 6-AN was added to a medium containing 0.05 µg/ml of niacin, the staphylococci were able to
grow at their normal rate.

However, when these cells were used

to estimate the glucose catabolic pathways, only 0.3% of the
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was found to be oxidized via the HMP pathway, the lowest

value ever observed with staphylococci.

Apparently this small

fraction is able to supply the pentoses and NADPH necessary for
growth.

With the use of isotopic studies, it has been shown

that in E. coli, about 1% of glucose carbon passing through the
oxidative part of the HMP pathway is converted into phosphoribosyl pyrophosphate, an intermediate for nucleotide synthesis
(11, 55).

On the basis of these findings it appears that one of

the primary functions of HMP pathway is to generate NADPH for
reductive biosynthesis.
From these data several conclusions can be drawn:

growth and for stimulation of glucose utilization
via the HMP pathway.
2 • . _High levels of operation of the HMP pathway

(i.e., 20-30%) are not required for maximal
growth rate.

When as little as 1% of the

glucose is being catabolized via the HMP
pathway, that rate is sufficient to allow
•

staphylococci to grow at their maximal rate.
under the conditions studied.
3.

The addition of niacin or its analogs can
stimulate the utilization of the HMP pathway
and the TCA cycle activity (when thiamine is
present) in the complete absence of growth.

r
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Impaired function of the HMP pathway in §_. aureus due to
the addition of 6-AN under growing and resting cell conditions,
was observed in our study (Table 14).

Such an inhibition of

the HMP pathway has already been demonstrated following 6-AN
administration in mammalian system (22,40,41,64).

The toxic

effects in animals, resulting from the administration of 6-AN
have been shown due to the formation of NAD(P) analogs in vivo,
which are inhibitory to a number of NADP-dependent dehydrogenases (17,41,64).

Herken (41) observed that there was a

considerable accumulation of 6-phosphogluconate compared to
glucose-6-phosphate, in the brains of 6-AN treated animals
In
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indicating a significant reduction in 6PGD activity.

Accu-

mulation of these substrates was not observed in the control
animals which did not receive 6-AN.
In parallel studies in this laboratory, it was shown that
the addition of 6-AN to the growth media resulted in a similar
accumulation of glucose-6-phosphate and 6-phosphogluconate (1.3
and 7.3 µmoles of G6P and 6PG/g, respectively) in staphylococci
(46).

This 5-fold increase of 6PG over G6P strongly suggested

that the site of action of 6-AN in
6PGD level.

s.

aureus was also at the

In the present study the activities of G6PD and

6PGD from 6-AN grown cells were not tested.

However, the resu-

ts of the isotope experiments with intact cells demonstrated

r
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that l~co2 evolution from glucose-1-14c was substantially
reduced, indicating that the two initial enzymes (G6PD and
6PGD) of the HMP pathway were inhibited.

On the basis of these

findings, it is not possible to conclude that reduction in the
HMP pathway utilization, accompanied by a 10-fold increase in
the substrates in S. aureus, was due to the formation of
coenzyrne analog of NAD(P).

However, it is clear from the

present study that in S. aureus the site of action of 6-AN
is also at 6PGD level, as observed in marrunalian system (41).
The results of the analog study indicated that none of the
hydroxylated pyridine derivatives replaced niacin, either for
;:>--·!lo-·· _._ __ ._

from Table 15 suggested that 6-hydroxynicotinic acid (6-HN)
stimulated the TCA cycle activity under certain conditions and
this thiamine-like effect was observed only in the cells that
had been previously grown in the presence of 6-HN and subsequently incubated in a medium containing added niacin.

The mecha-

nism for this stimulation of the TCA cycle activity by 6-HN
is not presently understood.

One possibility is that the analog
•
may cause derepression of thiamine biosynthesis in staphylococci
so that the cells may have enough of this vitamin for the
active operation of the TCA cycle.
synthesis in

~·

Derepression of thiamine

coli and Enterobacter species by compounds

such as adenine and phenylalanine, has been demonstrated (58,83).
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Ellinger et al.

(25) suggested that the growth promoting

activity of some pyridine derivatives for various niacin
requiring bacteria was due to slight contamination with niacin
or niacinamide of the pyridine derivatives.

The compounds

which stimulated growth fully, were also considered to be
heavily contaminated.

These suggestions were not based on any

direct experimental evidence.

However, since 3-acetylpyridine

(3-AP) and other analogs were required in such large amounts
(1000 µg/ml)

for staphylococcal growth stimulation, the possi-

bility was considered that this growth stimulation might
actually be due to contamination of the 3-AP by niacin or
. ,,
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niacinamide are not volatile, large quantities of this compound
were spotted on paper chromatograms.

Using different solvent

systems,
UV
spectra
and chemical
reactions, no contamination of
..
.
.
.
3-AP by niacin or niacinamide was detected.

With this technique

it would be possible to detect as little as 0.05 µg of niacin in
the 1000 µg of 3-AP.

Thus, when 5000 µg of 3-AP containing 0.05

µg of niacin was spotted on paper, this low amount of niacin was
detected in the mixture.

On the basis of these findings and the

limitation of the technique, any contaminating amount of niacin
must be present in a concentration less than 0.05 µg in 1000 µg
of 3-AP.

Such a low level of niacin, even if it was present,

could not account for the results reported in the present study
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with the analogs.

Using similar techniques it was also observed

that the growth stimulatory effects of NDA and quinolinic acid
were not due to their contamination with niacin and/or niacinamide.
The possibility was considered that the stimulatory effect
of the analogs on growth, glycolysis and on nicotinamide
coenzymes was due to the induction or derepression of niacin
biosynthesis.

In Saccharomyces cerevisiae the addition of the

thiamine analog oxythiamine (15 µg/ml) to the growth medium
stimulated the biosynthesis of thiamine (107, 108).

In the

present studies, with the use of 14 c-quinolinic acid and
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analogs was directly incorporated into the nicotin-amide coenzymes
(46) •

If the induction of niacin synthesis in the staphylococcal

cells was due to the addition of niacin analogs, then the incorporation of radioactivity from the analogs into NAD(P) would
not have occurred.

On the basis of these results it was con-

eluded that the stimulation of NAD(P) synthesis as a result of
the addition of niacin analogs was not due to the induction or
the derepression of niacin biosynthesis in staphylococci.

The

precise mechanism of this formation of nicotinamide coenzymes
from the analogs is not presently understood.

From the isotopic

data, and from various other types of evidence, it was concluded
that the stimulation of growth, of glycolysis and of NAD and

r
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NADP synthesis in staphylococci were all due to the increased
biosynthesis of unaltered nicotinamide coenzymes from the
analogs after the analogs had been modified biochemically
within the cells (46).
The need for high concentration of analogs to bring about
changes in the growth and in biochemical characteristics was
thought to be due to the reduced permeability for these
compounds.
Considerable evidence was obtained that the uptake of
14 c-niacin by staphylococci proceeded by a physiological
mechanism involving active transport (Fig. 6 to 10).
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and retained against a concentration difference and that the
transport appeared to be temperature-dependent (Fig. 8) and pH
sensitive (Fig. 7).

It should be noted that the niacin is

rapidly converted to NAD and NADP within the cells (33, 46).
Data presented in Fig. 10 showed that the rate of niacin uptake was increased when there were higher niacin concentrations
in the medium and that this process was saturated at a concentration of lo-7M (Fig. 10).

Similarly, the maximal rate of

niacin uptake was found to occur at pH 5.5 and at 50 C.

There

was relatively no uptake either at 4 C or at pH 4.0 and 8.0
(Fig. 7 and 8), indicating the transport system was both pH
and temoerature dependent.

r
147
The uptake of 14 c-quinolinic acid and 14 c-isoniazid by
niacin-deficient staphylococcal cells was negligible when the
suspensions were incubated with 1, 2, 10 or 50 µg/ml of the
analogs, for 2 hr at 37 C, in the presence of 1% glucose.

Only

a 2% increase in the uptake was observed when the concentrations
of either isoniazid or quinolinic acid were increased to 500
µg/ml.

Although the 14 c of the carbonyl-labeled does not end up

in NAD and NADP, the quinolinic acid-6- 14 c does (46).

Although

this uptake was low when compared to that of niacin, it was
sufficient to induce the biochemical changes in the staphylococcal cells reported earlier (Table 18).
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On the basis of these results,

it appeared that the niacin analogs entered the staphylococci by
simple passive diffusion •. An analogous situation was noted by
Kawasaki et al.

(57), who found that the uptake of thiamine in

E. coli occurred by an active transport process.

Upon isolation

of a mutant of E. coli that was defective in thiamine uptake,
they were able to demonstrate that the thiamine concentration
required for the half maximal growth for this mutant strain was
approximately 0.037 µg/ml, which was a concentration about 150fold higher than that required for the parent strain.

Results

with staphylococci in the present study also indicated that
100- to 1000-fold higher concentrations of niacin analogs than
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niacin were required for maximal growth, due to the lack of an
active transport for the

analogs~

E. coli, S. aureus and

~-·

megateri um (resistant to

isoniazid) have been shown to utilize extremely small amounts of
isoniazid compared to sensitive strains of .Mycobacteriurn
tuberculosis

(128).

In the present study it was also found that

staphylococci took up extremely small amounts of isoniazid, even
after exposure of cells for 6 hr (Fig. 11).
uptake studies with the analogs

On the basis of the

(Fig. 11 and 12), it is strongly

suggested that the need for high concentration for growth
stimulation and for the biochemical changes, is due to the
_.....,. _ _ _ _ _
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The analogs probably enter the cells by simple passive

diffusion after which they are able to cause changes similar to
those caused by niacin.

r

V. SUMMARY
S. aureus catabolized glucose by both the Embden-Meyerhof
(EM) and the hexosemonophosphate {HMP) pathways, as determined
with 14 c-1abeled glucose.

The relative activities of these

pathways, and of the TCA cycle, were influenced by the inclusion of niacin and/or thiamine in the growth medium.

When

> 0.25 µg/ml of niacin was added to 2% Vitamin-free Casitone,

the proportion of glucose metabolized via the HMP pathway by
S. aurues was stimulated 3-fold.

When 0.1 µg/ml of niacin

was added, the growth was maximally stimulated but increased
NAD(P) synthesis or HMP pathway activity was not observed.
Under growing conditions, increased glucose oxidation via the
HMP pathway and TCA cycle activity were correlated with the
increased synthesis of NADP-specif ic glucose-6-P dehydrogenase
·and isocitrate dehydrogenase, respectively.

When the vitamin

supplementation was made to resting niacin-deficient cells,
metabolic changes similar to those in growing cells occurred,
even in the presence of protein inhibitors such as chloramphenicol, puromycin or actinomycin D.

.Since the specific

activities of the enzymes tested remained unchanged under
conditions that precluded new enzyme synthesis, the enzyme
levels were not the limiting factors for glucose oxidation via

149
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the HMP pathway.
In order to determine if either NAD and/or NADP were
regulating the HMP pathway activity, the staphylococcal suspensions were starved for 6 hr in buffered-glucose (pH 7.0),
under conditions that allowed the NAD to decrease and NADP to
remain constant.

During the period of starvation the initial

NAD level decreased to 1 µmole/g and the percent of.glucose
oxidized via the HM2 pathway decreased to 9%, reaching a value
of 6% after 6 hr at which time the NAD content was further
reduced to 0.5 µmole/g.

When niacin was added, the NAD levels

and the HMP activity in these cells were increased to 1.2
urnu..Le:::; c:1.rru ..Lo-5.
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These results indicate that NAD is regulating the

activity of this expandable

(6 to 22%) HMP pathway, by in-

creasing NADP turnover via the transhydrogenase system.
Any of several 1-, 2-, 3- and 4-substituted niacin analogs
completely replaced the niacin requirement for both growth and
the HMP pathway utilization when added at high concentration
(ca. 1000 µg/ml)

to either a synthetic medium or Vitamin-free

Casitone supplemented with thiamine.

On the basis of their

effects on growth and on the HMP pathway the analogs were
classified into 4 groups.

The 22 group I analogs, including

pyridine-N-oxide, pyridine-3-sulfonic acid and 3-acetylpyridine,
stimulated both growth and the HMP pathway maximally while the
9 group II analogs, such as picolinic acid, stimulated growth

,..
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There were 13 analogs

and the HMP pathway to a lesser extent.

from group III, including 6-hydroxynicotinic acid, that were
without effect while 4 analogs from group IV, including 6arninonicotinarnide, were inhibitory.

Parallel experiments in

this laboratory using labeled quinolinic acid, isoniazid and
pyridine-N-oxide indicated that the analogs were converted to
NAD(P) and not to their analogs.

On the basis of the perme-

ability studies with the labeled compounds and 14 c-niacin, it
was suggested that the need for high concentrations of analogs
for growth was due to the absence of active transport for these
compounds and the analogs entered the cells .by simple passive

by niacin.

•
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